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A B S T R A C T 
The thymus is the primary lymphoid organ responsible for T cell production. It is 
of particular interest in the context of human immunodeficiency virus (HIV)-l infection, 
in which the progressive loss of CD4+ T cells leads to immunodeficiency and 
opportunistic infection. CD4+ T cell loss is thought to result from direct and indirect 
killing of C D 4 cells in the periphery as well as from pathogenic effects of the virus on the 
thymus. However, it is not fully understood which is the greater factor in viral-induced 
CD4+ T cell decay. 
The development of an assay to detect T cell receptor excisional circles (TREC) 
as a marker for recent T cell receptor (TCR) recombination in the thymus has proved to 
be an invaluable tool for the study of recent thymic emigrants. Here we describe the 
development of this technique in the rhesus macaque model and use this method in 
combination with other techniques to study the role of the thymus in maintenance of the 
peripheral T cell pool. 
This study has two major goals: to define the role of the thymus in peripheral T 
cell homeostasis in the juvenile rhesus macaque (Macaca mulatto) and to assess the 
significance of thymic output in the context of simian immunodeficiency virus (SIV) 
infection. To this end, we have studied the impact of surgical thymectomy on the 
peripheral T cell pool in a cohort of macaques. W e present evidence that thymic output 
in the juvenile macaque is measurable but quantitatively insignificant in the context of 
the total T cell pool. While SIV infection does have pathogenic effects on the thymus, 
these effects play a minimal role in the overall destruction of the peripheral T cell pool. 
2. Introduction 
2.1 Thymic Function 
2.1.1 Thymic Output in the Mouse In order to understand the capacity of the 
thymus to reconstitute the T cell pool after injury, it is crucial to determine normal thymic 
export rates. Data from a number of thymocyte labeling experiments using fluorescein 
isothiocyanate (FITC) and 5-(and 6-)-carboxyfluorescein diacetate, succinimidyl ester 
(CFDA, CFSE) to track recent thymic emigrants (RTE) in the periphery agree that only a 
small population of thymocytes leave the thymus each day, the remainder presumably 
dying by apoptosis during selection. Among the first such labeling studies using FITC to 
label thymocytes in mice demonstrated that 1% of thymocytes are exported each day, 
approximately 2xl06 cells per day(l). 1% of thymocytes exported per day has been 
observed using FITC labeling in pigs as well(2). 
Comparisons of bromodeoxyuridine (BrdU) uptake in dividing cells of 
thymectomized and euthymic mice reveal that BrdU labeling is of lower intensity in the 
thymus than in the spleen and lymph nodes. Thymectomized mice lacked the BrdU'0 
subset seen in sham thymectomized mice, while both groups had the BrdUhi subset(3). 
These BrdU'° cells were found to accumulate in the spleen and lymph nodes of sham 
thymectomized mice at a rate of approximately 0.9x106 cells per day, similar to the 
results observed using FITC labeling. 
2.1.2 Thymic Output in the Sheep CFSE has the advantage of remaining stable 
in cells for up to two months, allowing longer studies of RTE. Intrathymic injection of 
CFSE in 2 week old lambs confirmed an export rate of 1% of thymocytes per day. It was 
also observed that 7 4 % of the CFSE-labeled RTE localized to the spleen within the first 
24 hours, with equal proportions of the remainder in the blood and lymph nodes. After 
15 days, 5 1 % of R T E were found in the lymph node. The percentage of R T E in the 
blood was fairly constant during this period(4). Similar export rates and distribution of 
R T E were found using FITC injection in fetal sheep(5). In this experiment, it was 
observed that nearly 6 0 % of CD8+ R T E localized to the spleen in the first 24 hours 
postlabeling, while 6 0 % of CD4+ R T E localized to the lymph nodes. Approximately 
3 0 % of CD4+ and CD8+ R T E were found in the blood. These studies make no mention of 
the absolute number of thymic emigrants in the periphery, although it is expected that this 
number must be quite small. 
Intrathymic FITC injection in fetal sheep and 3 month old lambs demonstrated 
0.34% and 0.36% of thymocytes exported daily, respectively. This constant export rate 
translated to a total number of thymic emigrants per day increasing from 8.5xl07 in the 
120 day fetus to 4xl08 in the 3 month lamb. Interestingly, the smaller number of 
emigrants in the fetal sheep represented a higher concentration of cells, presumably as the 
thymus was seeding the peripheral pool(6). 
2.1.3 Age-Related Changes in Thymic Mass The progressive involution and 
atrophy of the thymus that occur with age were first documented by Galen. In the 1920s 
this phenomenon was studied by Hammar and others using data from autopsy (reviewed 
in(7)). At that time it was believed that the thymus grows until puberty before beginning 
this progressive involution. In the 1980s, Steinmann reviewed the data collected for 
earlier papers as well as a large number of healthy thymuses and concluded that in fact 
the thymus shows no evidence of growth beyond the first year of life, and maintains a 
constant size and weight(7). Thymic mass remains fairly constant due to the fact that as 
the thymus atrophies, lymphoid tissue is replaced by fat, a change evident both on 
autopsy as well as in computed tomography (CT) scans(7-10). 
2.1.4 Age-Related Changes in Thymic Output A corresponding age-related 
reduction in thymic function is currently under debate. Multiple lines of evidence 
indicate that thymic function persists with age, although the degree of output is uncertain. 
Thymopoiesis, as measured by the production of lymphocytes bearing the naive 
phenotype (CD45RA+CD62L+) is most active during childhood and declines in the later 
years of life(l 1, 12). However, small numbers of immature T cell precursors and mature 
thymocytes are found in the thymic tissue of normal individuals over the age of 60, and 
the distribution of thymocyte subsets is similar to that in childhood(7, 11, 13). The same 
distribution of thymic subsets is also observed in neonatal and aged sheep(14). Thymic 
diversity, as measured by T C R V(3 family usage, does not differ significantly between 
fetal and adult thymuses(15). T R E C have been measured in the peripheral blood of 
normal individuals up to the age of 95, and there is an age-related decrease in T R E C 
concentrations. Despite this decrease, significant T R E C numbers are detected in 
individuals over the age of 70(16-18). 
A more comprehensive study of age-related thymic export rates was done in 
sheep using FITC and CFSE injection. The total number of RTE recovered from the 
blood, spleen, and pooled lymph nodes 24 hours after labeling increased from 2.4xl08 in 
the fetal sheep to 15.3xl08 in the 2 week old lamb. This number decreased to 9.8xl08 in 
the 3-4 year old sheep. These numbers represented roughly 1 % of thymocytes exported 
daily at all ages, indicating that the age-related changes in thymic output are determined 
by the relative size of the thymus rather than export rates. The relative contributions of 
R T E to the peripheral T cell pool fell dramatically with age, resulting from the decreased 
size of the thymus and increased size of the peripheral T cell pool, rather than any 
reduction in thymic export rates(14). 
2.1.5 Age-Related Changes in the Peripheral T Cell Pool Along with age-
related changes in thymic output, there are alterations in the composition of the peripheral 
T cell pool. The elderly have decreased naive T cells (both CD45RA+ and CD62L+) and 
increased memory (CD45RO+) and activated (HLA-DR+) T cells compared to younger 
people. The elderly also have higher numbers of CD16+ natural killer (NK) cells, as well 
as CD3CD56+ N K cells and CD3+CD56+ T cells(19-21). 
The intensity expression of various T cell markers is also altered with age. CD3 
antigen expression is downregulated on total T lymphocytes as well as on memory T 
cells, but is upregulated on CD56+ T cells. Despite the greater numbers of activated T 
cells, the intensity of HLA-DR on those cells is decreased. Likewise, the expression of 
CD62L is increased although the numbers of those cells are decreased(19, 20). 
2.1.6 RTE in Peripheral T Cell Homeostasis A steady-state T cell pool requires 
balancing rates of input and loss. Naive and memory T cell subpopulations are believed 
to occupy separate niches, with long-lived naive cells dividing slowly and antigen-driven 
memory cells turning over at a higher rate(3, 22). Thymic output functions to maintain 
diversity within the naive population, which would be lost if the pool was maintained by 
peripheral expansion only(23). 
Despite this, there appears to be no homeostatic mechanism regulating thymic 
export. When additional thymic lobes were grafted into athymic and euthymic mice, 
0.7% of thymocytes, approximately 106 cells, were exported daily from both the natural 
and engrafted thymuses, regardless of the presence or absence of the other. This 
indicates that the thymic export rate is determined by the amount of thymic tissue 
present, and not the size of the peripheral pool(24). Although initial studies conflicted, it 
now appears that thymus grafting increases the T cell pool size in proportion to the 
number of grafted lobes(25). Thymic export also seems to be unaffected by peripheral T 
cell depletion induced by anti-CD4 or anti-Thy-1 antibodies(26). 
The fate of R T E within the naive T cell pool is debated. There is some evidence 
that R T E are transiently favored for survival over existing naive T cells(24, 25), while 
other studies demonstrate random deletion of RTE and other naive cells(27). 
The diversity created by thymic production of new T cells is particularly crucial 
following lymphocyte depletion. Although peripheral expansion also aids in the 
replenishment of the T cell pool, it cannot regenerate the quality of T cells produced by 
the thymus. T cells generated via peripheral expansion have the CD45RO+ phenotype 
and tend to display an oligoclonal T C R repertoire, while T cells produced in the thymus 
have the naive CD45RA+CD62L+ phenotype and a polyclonal TCR repertoire(23, 28, 29). 
2.2 Thymectomy and Thymic Deficiency 
2.2.1 Adult Thymectomy The frequency of thymoma in patients with 
myasthenia gravis led to the observation that thymectomy in that context is associated 
with an increase in muscle strength. Patients thymectomized for myasthenia gravis do not 
appear to have any decrease in peripheral T cell populations or humoral and cellular 
immune responses(30-32), and the mechanism for thymectomy's palliative effect remains 
unknown. 
2.2.2. Neonatal Thymectomy Neonatal thymectomy, in contrast, results in 
significant depletion of T cells in the periphery. Neonatal mice, when thymectomized, 
fail to mount an immune response to skin grafts(33, 34). Fetal sheep thymectomized in 
utero have at term only 10-20% of the recirculating pool of euthymic newborns, and 
lymphopenia in blood, spleen, and lymph nodes, as well as decreased cellular immunity 
(35, 36). Human neonates thymectomized during surgical repair of congenital heart 
defects had a decrease in T cell levels, but showed no evidence of immune compromise 
within the first year(37). However, human infants thymectomized before three months 
had evidence of impaired immunity in later childhood (38). 
2.2.3 Congenital Thymic Deficiency In congenital thymic deficiency such as 
complete DiGeorge syndrome in humans and the nude mutation in mice, the thymus fails 
to form and few T cells are generated(39-47). DiGeorge syndrome results from the 
maldevelopment of anatomic structures derived from the third and fourth pharyngeal 
pouches. The syndrome includes congenital heart defects, hypocalcemic tetany resulting 
from failed parathyroid development, multiple facial abnormalities, and maldevelopment 
of the thymic epithelium. Though patients with DiGeorge display a spectrum of thymic 
deficiency from mild to complete T cell deficiency, B cell levels are typically 
normal(48). 
2.2.4 Children with HIV-1 Infection Thymic function is thought to be a critical 
determinant of disease progression in HIV-1 infected children. HIV-1 infected children 
display two distinct modes of disease progression: exceedingly fast, with death occurring 
within two to three years of infection, and relatively slow with a pattern of progression 
similar to that found in adults, with death occurring five to ten years after infection(49-
52). In infants, rapid disease progression has been associated with low levels of CD4+ 
and CD8+ T lymphocytes, as opposed to low levels of CD4+ T lymphocytes and high 
levels of CD8+ T lymphocytes, and is thought to be related to thymic insufficiency 
resulting from infection early in life(52). 
2.2.5 Adults with HIV-1 Infection C T scans detect abundant thymic tissue in 
approximately 5 0 % of HIV-1-infected individuals with ages ranging from 20 to 59(13). 
The presence of thymic tissue was significantly associated with both a higher CD4+ T cell 
count and a higher percentage and absolute number of circulating naive 
(CD45RA+CD62L+) CD4+ T cells(13). Autopsy samples from individuals who died of 
complications of HIV-1 reveal that most patients do not have detectable thymic tissue, 
and when present, the thymus does not prevent prolonged lymphopenia(ll, 53). Limited 
case reports of HIV-1 infection in athymic adults suggest that disease progression is not 
altered by the absence of thymic tissue, and that thymectomy before FflV-1 infection did 
not prevent a clinical response to treatment or the regeneration of the peripheral T cell 
pool(53). 
2.3. Fetal Development of T Cells 
The thymus develops from the ectoderm of the third branchial cleft and the 
endoderm of the third pharyngeal pouch. Studies in embryonic mice suggest that the 
ectodermal layers give rise to the epithelium of the cortex, while the epithelium of the 
medulla arises from the endoderm(54). The rudimentary thymus, or thymic anlage, is 
colonized late in gestation in mice, but in humans the thymus is colonized in the first 
trimester, between weeks 7 and 9 of gestation in humans. CD7+ T cell precursors are 
present in the thorax, neck, yolk sac, and fetal liver before week 7, and by week 9.5 of 
gestation have colonized the thymus and are scattered throughout the fetal liver(55). 
The human fetal gut develops during week 4 of gestation. It is divided into the 
foregut, midgut, and hindgut by the arterial blood supply: the celiac, superior mesenteric, 
and inferior mesenteric arteries. Early on in week 4, branches of the celiac artery 
vascularize the liver, which is an outgrowth of the foregut. This provides a common 
blood supply and link between the developing gut and liver(56). 
y8 T cell receptors generated during human fetal development have been 
identified in the fetal liver during weeks 6-8 of gestation, before colonization of the 
thymus. These cells are biased towards Vy9/V52 use and are of limited diversity(57). 
Rearranged T C R 8 genes are also expressed in the developing gut between 6 and 9 weeks 
of gestation, and have a repertoire distinguishable from that observed in the liver and 
thymus(58). 
2.4. Extrathymic Sources for T Cell Production 
Extrathymic T cell development in the fetus and the presence of T cells in 
athymic mice and mice with genetic defects preventing T cell development via the 
thymic pathway have led to an examination of extrathymic sites of T cell 
differentiation(59-63). However, T cells originating outside of the thymus are different 
from thymic-derived T cells in phenotype and functional behavior. These cells are rarely 
found in peripheral lymphoid organs but are abundant in the gut epithelium, and may 
play a role in local immune response (reviewed in (64, 65)). 
The majority of extrathymic T cells appear to be NK1.1+ T cells. T C R diversity 
appears to be skewed in these cells(66-68), and there is evidence that dominant 
recombination between Val4-Jcc281 marks extrathymic selection of the T C R repertoire, 
and T R E C generated from this recombination event are detected in intestinal 
intraepithelial lymphocytes (IEL), bone marrow, liver, spleen, and Peyer's patches.(66). 
This skewed repertoire is positively selected by the M H C class I-like CDld molecule, in 
association with (^-microglobulin ((32m)(69). 
Overall, the picture of extrathymic T cell production is both localized and limited, 
and it is doubtful if it would be able to restore complete T cell function following 
depletion, in the absence of the thymic function. 
2.4.1 Intestinal Intraepithelial Lymphocytes The most abundant T cell 
population outside of the thymus is located in the intestinal mucosa. All gut 
intraepithelial lymphocytes (IEL) bear the aE|37 integrin (CD 103), which binds the gut 
epithelial E-cadherin(70). IEL are comprised of cells with heterogeneous phenotypes, 
and this heterogeneity provided the first clues that T cells can differentiate outside of the 
thymus. 
In the normal mouse, a major subset of IEL are phenotypically identical to 
thymus-derived peripheral blood T cells and display TCRa(3 and CD8a(3 or CD4, and are 
ThyT, CD5+, CD28+, and CD69+. These cells are also depleted of potentially autoreactive 
V P subgroups, evidence of repertoire selection in the thymus. 
A second subset of IEL is characterized by TCRa(3 or TCRy5, CD8aa 
homodimers, and are Thyl+/", CD5". and CD28". These cells are not deleted of potentially 
autoreactive V(3 subgroups, indicating that they do not undergo thymic selection(71). 
A third and minor subset of IEL are CD3" cells, which express recombinase 
activating gene (RAG)-l m R N A and are thought to be progenitors of thymus-
independent IEL(72, 73). These cells are increased in nude mice and are the only IEL 
population observed in scid and RAG"'" mice(65). 
2.4.2 Liver There is also evidence in mice for the liver as a site of extrathymic T 
cell production. The liver contains double negative (DN) CD4CD8" T cells that are 
TCRaP1"1, NKl.T, and IL-2Ri3+ (reviewed in(74)). c-kit+ stem cells in the liver have the 
potential to differentiate into lymphoid cells as well as granulocytes and erythrocytes(75-
77). 
Evidence that liver TCRint cells are of extrathymic origin comes from athymic 
nude mice, whose T cells are entirely TCR,nt(78, 79). These cells have skewed V|3 
subgroup use and have not undergone negative selection(68, 80, 81). 
2.4.3 Bone Marrow A third reported source for extrathymic T cells is the bone 
marrow. While the classical pathway for T cell development requires the migration of T 
cell precursors from the bone marrow to the thymus for maturation, there has been 
evidence that the bone marrow can also support the differentiation of these precursors 
into T cells(82). Like the extrathymic T cells reported in the liver, extrathymic T cells in 
the bone marrow are NK1.1+, and can be double negative as well as single positive(83). 
2.5. The Thymus and T Cell Dynamics in HIV-1 and SIV Infection 
2.5.1 T Cell Dynamics in HIV-1 Infection The central hallmark of HIV-1 and 
SIV infection is the progressive loss of CD4+ T cells. The mechanism for this remains 
unclear, but is likely to involve a combination of accelerated destruction and impaired 
regeneration. Highly active antiretroviral therapy (HAART) leads to a rapid decline in 
plasma viremia and concurrent rise in CD4+ T cells(84, 85). This led to the hypothesis 
that high levels of viral induced T cell destruction and demand on CD4+ T cell 
proliferation resulted in immune collapse(84-88). An alternate view suggests that the rise 
in CD4+ T cells after H A A R T reflects a redistribution of T cells trapped in peripheral 
sites by antigen, cytokine, or chemokine signals(89). 
Different methods to quantify T cell turnover in HIV-1 infected patients have 
reached conflicting conclusions. One approach, using telomere shortening as an indicator 
of replicative history, failed to detect telomere shortening in CD4+ T cells of HIV-1 
infected patients, suggesting normal or reduced CD4+ T cell tumover(90, 91). However, 
this method does not account for cells that have been destroyed and is biased towards 
non-dividing cells. Another approach is the measurement of nuclear antigen Ki67, 
specific for cell proliferation. Increased turnover of CD4+ and CD8+ T cells in HIV-1 
infected patients was demonstrated with this technique, in both the periphery and 
germinal centers of lymph nodes(92, 93). Thirdly, using the stable isotope-labeled 
metabolite 2H-glucose to measure T cell kinetics in vivo, it was demonstrated that the 
half-lives of both CD4+ and CD8+ T cells is decreased in late-stage HIV-1 disease(94). 
An initial study using deuterium-labeled glucose (D-glucose) as an in vivo label 
demonstrated higher levels of CD4+ and CD8+ T cell turnover in infection. However, 
these rates were even higher in patients treated with H A A R T , which led to the 
interpretation that a block in production is the basis for peripheral C D 4 decline(94). A 
more recent study using D-glucose labeling also demonstrated increased levels of CD4+ 
and CD8+ T cell turnover in infection. However, in this study both proliferation and 
death decreased following H A A R T , contradicting the concept of a lymphocyte 
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regenerative defect (95). These observations were supported by Ki67 as well as TdT-
mediated dUTP nick-end labeling (TUNEL), used as an indicator of apoptosis. 
2.5.2 T Cell Dynamics in SIV Infection A more direct measure of T cell 
proliferation in vivo has been obtained by studying SIV-infected rhesus macaques 
following the ingestion of BrdU, which is incorporated into the D N A of proliferating 
cells(96, 97). These studies demonstrated an increased turnover of CD4+ and CD8+ T 
cells as well as natural killer (NK) cells, suggesting generalized immune activation in 
SIV infection. 
2.5.3 HIV-1 Infection of the Thymus There is evidence that HIV-1 can infect 
the thymus and disrupt thymopoiesis. Thymuses from HIV-1-infected individuals 
demonstrate a wide range of morphologic abnormalities(49, 50, 53, 98-107). This is 
most pronounced in fetal and neonatal subjects. The HIV-1-infected thymus displays 
precocious involution associated with loss of lymphoid cells and profound stromal 
damage(49). These abnormalities have been associated with the presence of HIV-1 
antigen and HIV-1 R N A within thymocytes(108, 109). In some HTV-l-infected 
individuals there is enlargement of the perivascular space with CD8+ T cell 
infiltration(ll, 53). 
Further support comes from studies using in vitro thymocyte organ culture. 
Freshly isolated thymic tissue supports active HIV-1 replication in vitro and both 
immature and mature thymocytes are infected(101, 106, 110-113). Using thymic organ 
culture, it was observed that CD4+ T cells in the cortex are infected by HIV-1 and by day 
8 postinfection there is a significant depletion in CD3+CD4+CD8+ and CD3+CD4+CD8 
subsets(49, 100, 114). 
In addition, following inoculation of the SCID-hu mouse model with primary 
isolates of HIV-1, multiple thymocyte subsets are infected, including CD3"CD4+CD8" 
intrathymic T-progenitor cells, CD3+CD4+CD8+ cortical thymocytes, and CD3+CD4+ or 
CD3+CD8+ medullary thymocytes(98, 102, 115-126). Thymocyte depletion proceeds 
with disruption and loss of the cortical architecture and inversion of the normal CD4:CD8 
ratio in the medulla( 106, 114, 116, 118, 121, 124, 127). 
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2.5.4 SIV Infection of the Thymus Studies of SIV-infected neonatal and 
juvenile rhesus macaques have demonstrated a variety of thymic abnormalities following 
primary SIV infection(51, 128-134). In pig-tailed and cynomolgus macaques, infection 
with a chimeric HIV-1 and SIV virus (SHIV) or SIV has resulted in a marked depletion 
of thymocytes and disruption of thymic architecture(131, 135). Infectious virus has also 
been isolated from thymic samples from infected macaques(128). 
In a longitudinal study of the SIV-infected thymus, a dramatic increase in 
thymocyte apoptosis was observed seven to fourteen days after infection. This was 
followed by a depletion of thymic progenitors by day 21. By day 50, there was a rebound 
in thymocyte progenitors with some thickening of the thymic cortex, accompanied by 
increased proliferation of immature thymocytes. This increase in thymocyte progenitor 
activity may suggest an increased thymic output early in infection, before peripheral loss 
of CD4+ T cells is observed(129). However, it is not clear whether these observations 
correspond to an actual increased T cell output from the thymus. Moreover, it is not 
known how long the thymus can sustain this rebound. 
2.6. Role of the Thymus in Immune Reconstitution 
Regeneration of T cell numbers following lymphocyte depletion can occur via 
two mechanisms: thymopoiesis and peripheral expansion. T cells generated via 
thymopoiesis can be identified by the expression of CD45RA, whereas T cells generated 
via peripheral expansion tend to express CD45RO. In the presence of thymopoiesis, 
peripheral expansion is suppressed, but when thymopoietic pathways are limited, 
peripheral expansion is enhanced(136). While thymopoiesis engenders a diverse T C R 
repertoire and immune panel, the diversity of the T C R repertoire resulting from 
peripheral expansion is limited to the existing population and thus results in a suboptimal 
response to new antigens(23, 28, 29). 
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2.6.1 Bone Marrow Transplant In the mouse, thymic-competent hosts were able 
to rapidly restore normal T cell number and function after receiving lethal irradiation and 
subsequent bone marrow transplantation (BMT), while thymic-deficient hosts had 
prolonged T cell depletion(22, 136, 137). The thymus is also necessary for developing 
skin graft rejection and response to viral challenge following BMT(23, 138). 
There is evidence for an age-related reduction in thymic regenerative capacity, 
impacting on the balance between thymopoiesis and peripheral expansion. T cell 
regeneration following bone marrow transplant in patients under the age of 15 was rapid 
and involved CD4+CD45RAT T cells, whereas in patients over 18, reconstitution was 
slower and levels of CD4+CD45RAT T cells were low(139). Prolonged C D 4 depletion 
after bone marrow transplant is related to age-associated thymic impairment, even when 
peripheral blood progenitor cells are supplied(139-142). 
Infants with severe combined immunodeficiency (SCID) have vestigial amounts 
of thymic tissue and low numbers of circulating T cells, mainly CD45RO+ maternal cells. 
Restoration of normal peripheral T cell number and function was observed following 
treatment with haplotype-identical BMT(40, 143). After B M T , thymus-derived 
CD45RA1" cells appear, as do TREC, indicating that even a small amount of thymic tissue 
can produce T cells(144). 
While CD4+ cells require a functional thymus for regeneration, CD8+ cells seem 
to be under different regulatory requirements. Despite an age-associated C D 4 depletion 
following intensive chemotherapy, CD8+ T cells regenerate rapidly regardless of age or 
thymic enlargement(29). In one case of a thymectomized patient undergoing bone 
marrow transplant for mediastinal sarcoma, it was determined that CD8+CD45RA+ cells 
were able to regenerate as effectively as in thymus-bearing patients, but that 
CD4+CD45RA"" cells were unable to regenerate during 24 months following BMT(145). 
2.6.2 Treatment of HIV-1 Infection with Antiretroviral Therapy Treatment of 
HIV-1-infected individuals with H A A R T results in a dramatic decline in viral load and a 
significant increase in circulating CD4+ T lymphocytes(84, 85, 89, 146-149). These 
changes provide an opportunity to study the processes regulating T cell turnover, 
including the role of the thymus. 
13 
Like chemotherapy, it appears that the efficacy of H A A R T on CD4+ T cell 
reconstitution is age-dependent. In studies of HIV-1 infected children, there is a more 
significant early recovery of naive, memory, and total CD4+ T lymphocytes in those 
below three years of age than older children(150). In addition, the recovery rate of naive 
CD4+ T lymphocytes in patients below three years of age was 10- to 40-fold higher than 
previously reported in HIV-1-infected adults following HAART(150). This suggests that 
the contribution of the thymus to CD4+ T lymphocyte regeneration following H A A R T 
may be of great significance in children. 
In vertically infected infants, smaller thymic volume on magnetic resonance 
imaging (MRI) is correlated with lower CD4+ and naive CD4+ T cells and higher viral 
loads(107). With treatment, vertically infected infants had a decrease in viral load, an 
increase in CD4+ and naive CD4+ T cells, and reconstitution of the T C R V(3 repertoire. 
These were all shown to correlate to thymic volume, providing evidence for thymus-
mediated reconstitution of the T cell pool following HAART(151). 
A different pattern of regeneration is seen in HIV-1-infected adults following 
H A A R T . The initial rise in T lymphocytes within the weeks following therapy is 
primarily restricted to the memory (CD45RO+) population, whereas an increase in naive 
(CD45RA+CD62L+) T lymphocytes becomes more significant after six months of 
therapy(89, 146-148, 152). The mechanisms responsible for the early and late rise in T 
lymphocytes remain controversial. Some argue that the early increase in memory T 
lymphocytes is caused by T cell redistribution from lymphoid tissues to the 
periphery(89). Others believe that T cell proliferation in the periphery and/or increased 
thymic output after therapy may play the dominant role in T cell recovery(146-148, 152). 
Functional recovery of the T cell compartment is not complete unless the T C R 
repertoire is restored. Studies of the T C R repertoire changes by studying the varying 
lengths of the P chain CDR3 hypervariable region before and after H A A R T have yielded 
mixed results(147, 148, 152). The T cell repertoire is markedly disrupted through HIV-1 
infection and may be difficult to restore after HAART(147, 148). However, there are 
some reports implying that the T cell repertoire is not only restored but also can be 
expanded in diversity following H A A R T , suggesting an increase in naive T cells via a 
thymus-dependent regenerative pathway(89, 146, 152). Recent studies monitoring 
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changes in the number of T R E C after H A A R T support the latter notion(16). It was found 
that in 10 adult patients treated with H A A R T , there was a rapid and sustained increase in 
T R E C in almost all cases(16). In studies involving more patients, H A A R T had no 
appreciable effect on T R E C numbers in patients whose baseline levels are already within 
the normal range, while significant increases were seen in patients with a preexisting 
impairment 17). However, these T R E C increases were not sufficient to account for the 
rise in naive (CD45RA+CD62L+) CD4+ and CD8+ T lymphocytes. This suggests that the 
rise in naive T cells following H A A R T may not be a direct reflection of thymic 
output(17). It must be remembered that T R E C concentrations reflect cell proliferation 
and death as well as thymic output, and conclusions regarding thymic output cannot be 
made from these studies without the more detailed investigation of T R E C dynamics 
discussed in this work. 
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3. Methods for the Study of Thymic Function 
A phenotypic marker for recent thymic emigrants in humans has yet to be 
identified. While there are candidate markers such as the aE integrin (CD103)(153), no 
consensus has been reached as to their suitability. Various alternative methods for the 
study of thymic function have been developed, and the combination of these various 
approaches has yielded significant information about the role of the thymus in postnatal T 
cell homeostasis and regeneration following injury. 
One of the goals of this study is to describe the use of the al TREC, a recently 
developed molecular marker for RTE. W e have adapted the al TREC assay system to 
rhesus macaques in an effort to better understand the frequency and distribution of these 
episomes in the blood and lymphoid tissues, and to assess the role of thymic output and 
peripheral processes on recent thymic emigrants bearing this marker. 
3.1 Morphology and Imaging Studies In the first half of the twentieth century, studies 
of the thymus were limited to morphology and extensive autopsy studies of thymic mass, 
volume, and histology. Modem imaging studies of the mediastinum, such as C T scan and 
MRI, provide an estimate of thymic volume, and are a noninvasive means of studying the 
thymus in age and response to disease(7, 10, 154). While these techniques have the 
advantages of being noninvasive and feasible for use in humans, critics argue that 
lymphoid mass provides only a rough estimate of thymic function, and that as the adult 
thymus involutes, infiltrating fat makes imaging of lymphoid tissue difficult. 
3.2 CD45RA Differential expression of the CD45 isoforms have been used to 
distinguish naive from memory CD3+ T cells in humans(136, 139, 155-157). 
Coexpression of CD62L (L-selectin) with CD45RA further increases the specificity of 
naive T cell identification 158). The availability of cross-reactive antibody clones allow 
the identification of CD45RA+ naive T cells in the rhesus macaque as well. 
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The dynamics of the naive and memory T cell subpopulations complicate their 
use as indicators of thymic output. CD45RA" naive T cells have a long lifespan, and may 
persist in a resting state for years, while CD45RO+ memory T cells have a much shorter 
lifespan(159, 160). A major shortcoming of this technique is that in some cases 
CD45RO+ memory cells can revert to a CD45RA+ phenotype(161, 162). Therefore while 
R T E are expected to exist within the CD45RA" T cell population, CD45RA alone does 
not mark recent thymic emigration. 
3.3 Chtl The avian model of thymic function is unique in that there is a phenotypic 
surface marker for recent thymic emigrants. This marker, chTl, is probably the best 
existing marker for recent thymic emigrants. The percentage of cells bearing chTl 
declines rapidly following thymectomy in the chicken. In partial thymectomy, the 
percentage of chTl cells is directly proportional to the number of thymic lobes 
remaining(163). Unfortunately, this marker is only useful in the chicken model, as the 
human homologue of chTl is not a marker for recent thymic emigrants. A similar 
phenotypic marker for RTE in humans has not yet been described. 
3.4 Fluorescence Labeling Other studies of thymic function have relied on indirect 
methods for the detection of recent thymic emigrants in the periphery. In vivo thymic 
injection of fluorescent dyes such as FITC and C F D A have enabled researchers to track 
the movement of labeled thymocytes into the blood and peripheral lymphoid organs(4-6, 
14, 164). The advantage of in vivo injection of fluorescent dyes is that it provides a means 
of readily identifying RTE by flow cytometry; however, injection is a technically difficult 
surgical procedure, and recovery of fluorescent R T E often necessitates sacrificing the 
animal. Obviously, this technique is not appropriate for humans. 
Uptake of BrdU, a D N A precursor, enables the identification of dividing cells. In 
mice, cells of thymic origin have a lower intensity of BrdU labeling than cells in the 
spleen and lymph node, allowing discrimination between the two(3, 165, 166). BrdU can 
be given in the drinking water, and thus has the advantage of being noninvasive, but it 
labels all dividing cells and thus has limited utility in thymic studies apart from those 
described. Use in humans is limited due to potential cytotoxicity. 
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3.5 T Cell Receptor Excisional Circles A recent addition to these methods is the use of 
T cell receptor excisional circles to detect recent rearrangement of the T cell receptor in 
newly developed T cells. Progenitor cells in the thymus destined to become a(3 T cells 
must first delete the 8 locus from the a locus on the chromosome(167, 168). One such 
recombination event is found to occur in 7 0 % of human a(3 T cells, and produces an 
89. lkb T R E C (al circle)(169). Other detectable T R E C result from TCRf3 chain 
rearrangement 18). T R E C are stable within the cell, but are diluted by cell division and 
lost with cell death. T R E C in the blood can serve as a marker for RTE, although 'recent' 
refers to the number of cell divisions since leaving the site of rearrangement rather than 
the time elapsed. Further support for TREC as a marker for RTE comes from the chicken 
model, as T R E C have been shown to correlate with chTT T cells in the chicken(163, 
170). T R E C measurements can be performed on peripheral blood, which makes it ideal 
for use in humans and primates, and T R E C concentrations can be followed for long 
periods of time, enabling longitudinal assessment of thymic output in various disease and 
recovery states. 
4. Materials and Methods 
4.1 Rhesus Macaques (Macaca mulatta) All rhesus macaques used in this study were of 
Indian origin and were housed at the Tulane Regional Primate Research Center, 
Covington, LA. All animals were screened for simian retrovirus (SRV) before being 
assigned to the study and were subsequently moved to single animal cages. All animals 
were maintained in accordance with NIH guidelines and approval of the Institutional 
Animal Care and Use Committee. 
For blood draws, anesthesia was induced with ketamine hydrochloride (lOmg/kg, 
IM) and analgesia was provided via butorphanol (0.013mg/kg, IM). The standard method 
of euthanasia for nonhuman primates was used, anesthesia with ketamine HC1, lOmg/kg, 
followed by an overdose with sodium pentobarbital. This method is consistent with the 
recommendation of the American Veterinary Medical Association's Panel on Euthanasia. 
4.2 Surgical Thymectomy Surgery was performed by Drs. lames Blanchard and 
Rudolph Bohm at the Tulane Regional Primate Research Center. Before surgery, each 
animal was pre-anesthetized with acepromazine (O.lmg/kg), buprenophrine (0.01 mg/kg), 
and glycopyrrolate (0.01 mg/kg) half an hour before the procedure. The animals were 
then anesthetized with ketamine HC1, lOmg/kg, intubated and placed on isofluorane gas, 
1.5-2.5% to effect and oxygen through inhalation during surgery. Intermittent positive 
pressure ventilation is used to maintain respiration at a rate of 10-15 breaths per minute. 
The approach was via a ventral sternotomy using an oscillating bone saw and 
scissors. The initial skin incision began at the level of mandibular ramus in the ventral 
cervical region and extended caudally, 2/3 the distance of the sternum. The sternotomy 
likewise extended from the manubrium 2/3 the distance of the sternum, leaving the 
caudal 1/3 of the sternebrae intact. The thymus was freed from the pericardium using 
blunt dissection. The dissection was continued cranially over the cranial thoracic vessels 
and into the cervical region. The limits of dissection in the ventral cervical area are: the 
internal jugular veins laterally, and the thyroid glands cranially. After removal of the 
largest part of the gland, dissection was completed by removing small remnants of fat and 
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thymus in piecemeal fashion. Saline was used to lavage the surgical site after dissection 
was completed. A thoracotomy tube was placed through the thoracic inlet period to 
closure. Air and fluid were aspirated as the tube was withdrawn. The rate of assisted 
ventilation was decreased to 6 breaths per minute at the time of closure. Closure was 
completed using simple interrupted 2.0 vicryl suture in the sterebrae and 3.0 vicryl in a 
simple continuous pattern in the musculature. Subcutaneous closure was performed 
using 3.0 vicryl in a simple continuous pattern and the skin was closed using 3.0 nylon in 
a simple interrupted pattern. Assisted ventilation was discontinued at the end of 
procedure. Postoperative thoracic radiography was performed to verify reduction of 
pneumothorax. Postsurgery, buprenorphine (O.lmg/kg) was given for three days for pain. 
Sham animals underwent the same surgery without removal of the thymus. 
4.3 Sample Collection Blood samples were drawn into vacutainers containing EDTA as 
an anticoagulant and shipped overnight on ice. Upon receipt of the samples, whole blood 
was removed as needed for TruCount and antibody staining before centrifugation. 
Plasma was removed and banked at -70°C, and peripheral blood mononuclear cells 
(PBMC) were isolated by gradient centrifugation with Ficoll-Paque (Pharmacia, Peapack, 
NJ) or Cellgro Lymphocyte Separation Medium (Mediatech, Herndon, VA). P B M C 
were pelleted and frozen at -70°C for D N A and R N A extraction or frozen viably at 
150°C in 9 0 % fetal calf serum (FCS) with 10% dimethyl sulfoxide (DMSO). 
4.4 Flow Cytometry Absolute CD4 and CD8 counts were obtained from 50ui of whole 
blood using TruCount tubes (BD PharMingen, San Diego, C A (BD)) and the following 
monoclonal antibodies: anti-CD3-PE (BD), anti-CD8-PerCP (BD), and anti-CD4-APC 
(Exalpha, Boston, M A ) . 
Quantitation of CD3+, CD4+, CD8+, CD20+ and CD45RA+ subpopulations was 
done by four-color flow cytometry using the following monoclonal antibodies: anti-CD3-
FITC clone FN18 (Biosource International, Camarillo, CA), anti-CD3-biotin (Biosource), 
streptavidin-PerCP (BD), anti-CD20-PE (BD), anti-CD8-PerCP (BD). anti-CD8-APC 
(BD), anti-CD4-APC (Exalpha), and anti-CD45RA-FITC (BD). 
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For intracellular Ki67 staining, 100|il of whole blood was incubated with anti-
CD3-biotin (Biosource), anti-CD8-PerCP (BD), and anti-CD4-APC (Exalpha). After 30 
minutes, erythrocytes were lysed and cells were permeabilized for 15 minutes at room 
temperature with F A C S Lysing Solution (BD). Samples were washed three times with 
PBS and incubated for 30 minutes with anti-Ki67-FITC (DAKO, Carpinteria, CA) and 
streptavidin-PE (BD). After two more washes the samples were resuspended in 2 % 
formaldehyde (Tousimis Research Corp., Rockville, M D ) For each sample, an isotype 
control incubated with a mouse immunoglobulin Gl (IgGl)-FITC antibody (Caltag 
Laboratories, Burlingame, CA) instead of anti-Ki67-FITC was processed in parallel. 
All analyses were performed with a FACScalibur flow cytometer and Cellquest 
software (BD). 
For fluorescence activated cell sorting of double positive and single positive 
thymocytes, cells were stained with anti-CD3-FITC (Biosource), anti-CD4-PE (Exalpha), 
and anti-CD8-APC (BD). Cells were gated on CD3 and sorted into CD4+CD8+ double 
positive and CD4+ and CD8+ single positive cells. 
4.5 Magnetic Cell Sorting CD4+ cells were obtained from PBMC using positive 
selection with anti-CD4 M A C S microbeads according to the manufacturer's instructions 
(Miltenyi Biotec). The negative fraction was collected and used for a second round of 
positive selection with anti-CD8 M A C S microbeads. Both CD4+ and CD8+ cells were 
pelleted and frozen at -70°C for D N A extraction and TREC analysis. 
4.6 Quantifying Plasma SIV Viral Load by Real-Time PCR This system of 
quantifying plasma SIV viral load by real-time PCR with molecular beacon has been 
described previously (171). To measure the viral load of infected monkeys, plasma was 
separated from whole blood collected in EDTA-containing tubes. Plasma samples were 
initially spun at 5,000 rpm for 10 min to remove any cells. Viral R N A was purified from 
140ul of plasma using the QIAamp viral R N A kit (Qiagen Inc., Hilden, Germany). 
Reverse transcription of viral R N A was performed in 96-well plates. Each 30u,l 
reaction contained the following: 10u.l of viral R N A , IX Taqman Buffer A (Perkin-
Elmer, Boston, M A (PE)), 5 m M MgC12, 2.5|xM random hexamers (PE), 0.5mM each of 
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dATP, dCTP, dGTP, and dTTP (Roche), 20 U RNAsin (Promega, Madison, WI), and 20 
U Moloney murine leukemia virus reverse transcriptase (Superscript; Gibco BRL, 
Carlsbad, CA). One round of reverse transcription (25°C for 15 min, 42°C for 40 min, 
75°C for 5 min) was performed. 
To quantify the copy number of viral R N A , a molecular beacon was used in 
combination with real-time PCR. This method of detection using molecular beacons 
(172, 173) and a fluorescence detector system (174) has been described previously. Each 
50rU,l reaction contained the entire 30(xl of c D N A from the reverse transcription reaction, 
and the final concentration of each component was as follows: IX Taqman buffer A, 3.5 
m M MgC12, 0.4 pmol/ixl of molecular beacon, 0.4 pmol/u.1 of each primer, 1.25 U of 
AmpliTaq Gold D N A polymerase (PE). 
The primers used were SL03 (5'-AGGGAAGAAAGCAGATGAATTA-3') and SL04 (5'-
GTTTCACTTTCTCTTCTGCGT-3'). The molecular beacon was designed to recognize a 
region within SIV gag ( 5 ' - F A M - C G C T G G A G A A C A A A G A A G G A T G T C A C A G C G -
DABCYL-3') where F A M (6-carboxyfluorescein) serves as the reporter fluorochrome 
and D A B C Y L (4' dimethylaminophenyiazo benzoic acid) the quencher. One cycle of 
denaturation (95°C for 10 min) was performed, followed by 45 cycles of amplification 
(95°C for 15 s, 55°C for 30 s, 72°C for 30 s). The PCR reaction was carried out in an ABI 
7700 PRISM spectrofluorometric thermal cycler (Applied Biosystems, Inc., Foster City, 
C A ) that monitors changes in the fluorescence spectrum of each reaction tube, while 
simultaneously carrying out programmed temperature cycles. 
Each test specimen was reverse transcribed and amplified in duplicate. A third 
reaction was processed and amplified without the addition of reverse transcriptase to 
control for potential D N A contamination. Copy numbers were calculated by interpolation 
of the experimentally determined threshold cycle as described previously (174). The 
mean of duplicate samples was reported. 
4.6.1 Generation of RNA Standards for Real-Time PCR of RNA Species This 
method of quantifying viral load was adapted from a previous report (174) with some 
modifications. For each run, a standard curve was generated from duplicate samples of 
purified R N A transcripts ranging from IO6 copies to 10 copy equivalents per reaction. To 
generate R N A standards, the SIV-gag amplicon was generated with a 5' T7 promoter by 
extension P C R using primer S L 0 3 T 7 (5' 
T A A T A A C G A C T C A C T A T A G G G A G G A G G G A A G A A A G C A G A T G A A T T A - 3 ' ) and 
SL04. R N A was generated by in vitro transcription using the Megascript T7 High Yield 
Transcription Kit (Ambion, Austin, TX) according to the manufacturer's instructions. 
R N A was treated twice with RNase-free DNase I (Boehringer Mannheim, Ingelheim, 
Germany). Copy number was determined using optical density and the molecular weight 
of the R N A species, and serial dilutions were made in RNAse-free water. Standards were 
stored at a concentration of lxlO7 copies/ixl in single-use tubes, and serial dilutions were 
made from IO6 copies to 10 copies with each run. 
4.7 Isolation of Intestinal Epithelial and Lamina Propria Lymphocytes This method 
of isolating viable intestinal epithelial and lamina propria lymphocytes has been 
described previously (175, 176). Tissue was removed from the animal during surgical 
biopsy or within 30 minutes of euthanasia. For necropsy, 6-10 cm lengths of intestine 
were taken from ileum, jejunum, and colon. For biopsy, smaller sections were taken 
from terminal ileum and cecum. Fat, mesenteries, and visible blood vessels were 
carefully removed. The intestine was cut open with sharp scissors to expose mucosa, 
washed with PBS until all visible chyme was removed, and placed into 50ml tubes with 
PBS for transport to lab. Pieces remained moist throughout procedure. 
4.7.1 Intraepithelial Lymphocyte (IEL) Isolation Tissue was cut into 0.5-1.0 
cm square pieces with a razor blade and placed into 25cm2 plastic tissue culture flasks 
with 25-30ml of IEL separation media consisting of Complete Hanks balanced salt 
solution (HBSS) containing 100 IU/ml penicillin/streptomycin, 2 m M glutamine, 2 5 m M 
Hepes buffer, 5 % fetal calf serum (FCS), 1 m M E D T A (anhydrous, M W 280) adjusted to 
pH 7.2-7.4. Flasks were incubated for 30 minutes at 37°C with rapid shaking. 
Supernatant was collected into 50 ml tubes using a stainless steel screen cup (Sigma) 
which allows cell rich supernatant to pass through but blocks mucus and debris. Cells 
were washed and resuspended in 30ml RPMI-1640 containing 100 IU/ml 
penicillin/streptomycin, 2 m M glutamine, and 10% FCS (R-10) after each incubation and 
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stored on ice during the procedure. The incubation was repeated two more times in fresh 
IEL separation media and pooled cells were resuspended in R-10 on ice. 
4.7.2 Lamina Propria Lymphocyte (LPL) Isolation After IEL removal, 
remaining intestinal segments were minced with scissors into 2-3mm pieces and 
transferred into a clean 25cm2 flask with 25-30ml of LPL separation media consisting of 
RPMI-1640 containing 100 IU/ml penicillin/streptomycin, 2 m M glutamine, 2 5 m M Hepes 
buffer, 5 % FCS, and 50 U/ml collagenase type II (Sigma). Flasks were incubated for 30 
minutes at 37°C with rapid shaking. Supernatant was collected into 50ml tubes using a 
stainless steel screen cup, and cells were washed and resuspended in 30ml (R-10) after 
each incubation and stored on ice during the procedure. The incubation was repeated two 
more times in fresh LPL separation media and pooled cells were resuspended in R-10 on 
ice. 
4.7.3 Lymphocyte Enrichment Lymphocytes were isolated from the pooled 
supernatants with Percoll bilayer density gradient centrifugation. Isotonic Percoll (one 
part lOx PBS with 9 parts Percoll (Sigma)) to prepare 3 5 % and 6 0 % Percoll solutions 
with R-10. 2ml 6 0 % Percoll was overlaid with 2ml 3 5 % Percoll in 15ml polypropylene 
centrifuge tubes. The gradients were refrigerated for at least 1 hour before use. 2-3 
gradient tubes were used for each pooled sample. 10ml of the pooled cell suspension was 
overlaid onto each gradient and centrifuged at lOOOg for 20 minutes with no brake. 
Lymphocytes were removed from the 35%/60% interface and washed with R-10. Cells 
were counted with Trypan blue to assess viability and frozen at -150°C in 9 0 % FCS with 
10% D M S O or pelleted at -70°C for D N A extraction. 
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4.8 Real-Time P C R Detection of al T R E C The method of detection using molecular 
beacons (172, 173) and a fluorescence detector system (174, 177, 178) has been 
described previously. Genomic D N A was extracted using the QIAmp D N A extraction 
kit (Qiagen) according to the manufacturer's instructions. To detect al TREC, molecular 
beacon was used in combination with real-time PCR. 
Each 50(0.1 reaction contained 5uT of genomic D N A , and the final concentration of 
each reagent was as follows: IX Taqman buffer A (PE), 3.5 m M MgCl2, 0.2mM each of 
dATP, dCTP, dATP, dTTP (Roche, Basel, Switzerland), 0.4 pmol/u.1 of molecular 
beacon, 0.4 pmol/u.1 of each primer, and 1.25 U of AmpliTaq Gold D N A Polymerase 
(PE). 
The primers used were ST3 (5'-GGATGGAAAACACAGTGTGACATGG-3') 
and ST4 (5'-CAACCATGCTGACGCCTCTGG-3'). These primers amplified a 182-bp 
product. The molecular beacon, ST2, was designed to recognize a region upstream from 
the signal joint. ( 5 ' - F A M - C G G C G T C T G C T C T T C A T T C A C C A T T C T C A C G C C G -
DABCYL-3') where F A M (6-carboxyfluorescein) serves as the reporter fluorochrome 
and D A B C Y L (4' dimethylaminophenylazo benzoic acid) the quencher. One cycle of 
denaturation (95°C for 10 min) was performed, followed by 45 cycles of amplification 
(95°C for 30 s, 60°C for 30 s, 72°C for 30 s). The PCR reaction was carried out in an ABI 
7700 PRISM spectrofluorometric thermal cycler (Applied Biosystems, Inc.) that monitors 
changes in the fluorescence spectrum of each reaction tube, while simultaneously 
carrying out programmed temperature cycles. 
To normalize for cell equivalents in the input D N A , we used a separate real-time 
PCR/molecular beacon assay to quantify the CCR5 coding sequence, as it is known that 
this gene is present at exactly two copies per cell, with no pseudogenes (L. Kostrikis, 
personal communication). 
For the CCR5 assay, each 50u,l reaction contained 5u.l of genomic D N A , and the 
final concentration of each reagent was as follows: IX Taqman buffer A (PE), 3.5 m M 
MgCl2, 0.2mM each of dATP, dCTP, dATP, dTTP (Roche), 0.4 pmol/u.1 of molecular 
beacon, 0.4 pmol/u.1 of each primer, and 1.25 U of AmpliTaq Gold D N A Polymerase 
(PE). 
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The primers used were CCR1 (5'-GCTGTGTTTGCCTCTCTCCCAGGA-3') and 
LK47 (5'-CTCACAGCCCTGTGCCTCTTCTTC-3'). These primers amplified a 182-bp 
product. The molecular beacon was L K 1 5 5 , (5' T E T 
G C G C C T A T G A C A A G C A G C G G C A G G A G G C G Q - D A B C Y L - 3 ' ) where T E T 
(tetramethylrhodamine) serves as the reporter fluorochrome and D A B C Y L (4' 
dimethylaminophenylazo benzoic acid) the quencher. One cycle of denaturation (95°C 
for 10 min) was performed, followed by 45 cycles of amplification (95°C for 30 s, 60°C 
for 30 s, 72°C for 30 s). 
4.8.1 Generation of M13 Bacteriophage Standards for Real-Time PCR of 
D N A species M 1 3 bacteriophage D N A standards were made as follows: The amplicon 
of interest was generated using the appropriate primers for the assay and a Pfu 
polymerase to generate a blunt ended product. The product was purified on a 1% agarose 
gel and ligated into M 1 3 m p 18 RF D N A (Gibco) according to manufacturer's 
instructions. The ligation product was used to transform DH5aF'competent cells 
(Gibco). Plaques generated from phage containing inserts were identified using 
blue/white selection for the absence of P-galactosidase activity. Positive plaques were 
screened by PCR using primers M13/pUC-f (5'-CCC A G T C A C G A C G T T G T A A A ACQ-
S') and M13/pUC-b (5'-AGCGGATAACAATTTCACACAGG-3') in a 30 cycle PCR 
(95°C for 30 s, 55°C for 30 s, 72°C for 1 m). Fragments of the correct size were further 
screened by sequence analysis. Bacteriophage was titered and serial dilutions were made 
in RNAse-free water. Bacteriophage was put directly into the PCR reaction, as the 10 
minute 95° denaturation step was sufficient to expose the phage DNA. 
An external standard curve was generated for each real-time PCR assay using a 
minimum of 6 replicates ranging from 2.5xl06 to 2.5xl0]. As the phage is single 
stranded, one particle corresponds to 0.5 double-stranded D N A copies in the real-time 
PCR assay. Each PCR plate also contained duplicate internal standards in the same 
range, and these were compared to the external standard curve to validate the run and 
check for standard degradation. Phage standards were stable at 4°C, although stocks were 
maintained at -20°C. 
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4.9 T C R P C D R 3 Profile Analysis R N A was isolated from P B M C using the Qiagen 
RNeasy R N A Extraction Kit (Qiagen) according the manufacturer's instructions. c D N A 
was generated by a reverse transcription reaction as follows: R N A was denatured at 
70°C for 10 minutes, then placed on ice and combined with a mixture containing final 
concentrations of IX First Strand Buffer (Gibco), 0.0IM D T T (Gibco), 0.5mM each of 
dATP, dCTP, dGTP, and dTTP (Roche), and 5u.M random hexamers (Perkin-Elmer). 
R N A was allowed to prime at 25°C for 10 minutes followed by 42°C for 2 minutes. 20 U 
Moloney murine leukemia virus reverse transcriptase (Superscript; Gibco) was added and 
reverse transcription took place at 42°C for 50 minutes followed by 70°C for 15 minutes. 
c D N A was PCR amplified for 24 V P families by using individual VP-specific 
primers and a CP-specific primer as described previously(179) (Table 1). The entire RT 
reaction mixture was divided equally among 25 50uJ first round PCR reactions 
containing final concentrations of IX PCR buffer II (PE), 3.5mM MgCl2, 0.2mM each of 
dATP, dCTP, dTTP, and dGTP (Roche), 0.4pmol/(xl of primer 3CB and of the 
appropriate V P family primer 1-25, and 1.25 U of AmpliTaq Gold D N A Polymerase 
(PE). Reaction conditions were 95°C for 1 m 30 s, 35 cycles of 95°C for 30 s, 52°C for 
30 s, 72°C for 30s, and a final extension of 72°C for 9 m 30 s. 
5u,l of first round PCR product was placed into a second round of heminested 
PCR performed with the same VP primers and an inner CP primer labeled at its 5' end 
with the F A M fluorophore. All other reagents and reaction conditions were the same as 
above. The P C R products were purified using the QIAquick PCR Purification Kit 
(Qiagen) and eluted into 50|il of RNAse-free water. 
C D R 3 profiles were analyzed by Genescan-based spectratyping(180). 0.2ul of 
each PCR reaction was mixed with deionized formamide (Amresco, Solon, O H ) and a 
ROX-500 size standard (Applied Biosystems, Warrington, England) and electrophoresed 
on a 5 % acrylamide gel on an ABI 377 D N A sequencer (Applied Biosystems, Foster 
City, CA). Components of the gel were Long Ranger Gel Solution (Biowhittaker 
Molecular Applications, Rockland, M D ) , T B E (Promega, Madison, WI), urea (Fisher 
Scientific, Fair Lawn, NJ), ammonium persulfate (Promega), T E M E D (Promega), and 
H-,0. Data were analyzed for size and fluorescence intensity with the Genescan software 
(Applied Biosystems). 
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4.10 Statistical Analysis Absolute T cell decay slopes and al TREC decay slopes were 
calculated based on the natural log of the number of cells. The nonparametric Mann-
Whitney U test was used to compare sets of slopes. Statistical analysis was performed 
using StatView software, p values < 0.05 were considered statistically significant. 




























































































































































































































































5.1 Development of a Real-Time PCR/Molecular Beacon Assay to Quantify TREC 
as a Measure of Recent Thymic Emigrants in the Peripheral Blood. 
5.1.1 TREC as a Marker for Recent Thymic Emigrants The variability among 
T cell receptors is generated by site-specific recombination within the chromosomal 
D N A . Multiple variable (V), diversity (D), and joining (J) regions are encoded within the 
T C R loci. These recombine at the D N A level to form the genes for the T C R a, P, y, and 
8 chains. 
Somatic recombination occurs at conserved recombination signal sequences 
(RSS) that flank the multiple V, D, and J segments. Each RSS contains a conserved 
heptamer and nonamer sequence, separated by a nonconserved spacer of 11/12 or 22/23 
base pairs. The "12-23" rule governing recombination dictates that an RSS with a 12 
nucleotide spacer combines with an RSS containing a 23 nucleotide spacer, ensuring that 
gene segments recombine in the functional order of V(D)J (181). 
Recombination at the T C R loci mainly occurs via deletion of the D N A separating 
the RSSs of the V, D, or J segments. Two joints are formed by the recombination event. 
The "coding joint" is formed within the chromosomal D N A between the recombining 
elements. This joint often contains base pair insertions or deletions, increasing variability 
among T cell receptors. The "signal joint" is formed by the conserved joining of the two 
heptamer sequences of the RSSs. This joining serves to link the ends of the excised 
chromosomal D N A , forming an episomal byproduct of T C R rearrangement 182-184). 
These deletion circles are termed T-cell receptor excisional circles (TREC). 
V(D)J recombination is mediated by the recombinase activating genes, RAG-1 
and RAG-2. RAG-1 and RAG-2 are encoded within the same locus on chromosome 1 lp 
in humans (chromosome 2 in the mouse)(185-189). Expression of RAG-1 and RAG-2 
occurs at two points in thymocyte development. The first occurrence is in the double 
negative (DN) stage, and corresponds to TCRP, y, and 5 m R N A expression. The second 
is in the double positive (DP) stage, and corresponds to T C R a m R N A expression(190). 
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Somatic rearrangement of the T C R loci precedes surface expression of the T C R . 
V(D)J recombination at the various T C R loci occurs in a sequential manner. A small 
percentage of T cells express a T C R y:8 heterodimer, and these T cells arise from the 
same progenitor as a:p T cells, p, y, and 8 genes rearrange simultaneously; successful 
rearrangement of the y and 8 genes leads to expression of a y:8 T C R . However, in some 
cases successful P gene rearrangement occurs first, and P chain protein expression with 
the invariant partner chain pre-Ta blocks further y and 8 rearrangement. Expression of 
this pre-T receptor signals for proliferation and induces the expression of C D 4 and C D 8 . 
During this proliferation phase, R A G - 1 and R A G - 2 are repressed, and no recombination 
takes place. Once many D P thymocytes expressing the same P chain are present, 
proliferation ceases and R A G - 1 and R A G - 2 are expressed and function in the 
recombination of the a chain gene. Thus a single p chain heterodimerizes with multiple 
a chains in different cells, increasing the range of antigen specificity(54). 
Germline TCR-a/6 locus TCR 6 locus 
1 D5 J6 ' 
Va V61 Va &Rec V62 | , 2 3 ~—T~P C6 V63 '<'Ja 160 59 58 
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Figure 1. Recombination at the T C R a locus to delete the TCRo locus. Recombination 
between 6Rec (in green) and tyJa (in red) forms the TCRa coding joint as well the 89.1 Kb al 
TREC containing the signal joint. 
The T C R a chain locus encompasses the 8 locus, and in the majority of cases, the 
initial recombination of the a locus occurs between two regions termed SRec and \|/Ja in 
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such a way as to delete out the entire 8 locus, forming an 89.1 episome termed the al 
TREC. (Fig. 1). Douek et al. used QC-PCR to quantify this particular TREC(16). In a 
study of 25 normal individuals, they found that the number of al T R E C in the blood 
decreased by 1-1.5 log between birth and age 73, and that low al T R E C numbers in 10 
HIV-1 infected patients were increased after treatment with H A A R T . 
5.1.2 Development of a Real-Time PCR/Molecular Beacon Assay to Quantify 
al T R E C in Humans. W e developed a real-time PCR/molecular beacon assay to 
quantify this al T R E C as a measure of recent thymic emigants (RTE) in peripheral 
blood(17). W e designed an assay to amplify a 209-nucleotide fragment spanning the 
signal joint of the excised al T R E C using PCR. A molecular beacon was included in the 
reaction mixture throughout PCR to serve as a real-time detector for the amplified 
product. The beacon is specifically designed to have a hairpin structure, with a 6-bp stem 
and a 26-nucleotide target recognition loop, plus a fluorophore and a quencher in close 
proximity at the two ends of the oligonucleotide. During the annealing phase of PCR, the 
molecular beacon binds to its target. This event strips open the stem, physically 
separating the fluorophore from the quencher and allowing fluorescence to be emitted. 
Fluorescence emission is detected in real time using a spectrofluorometric thermocycler. 
As the PCR fragment is amplified, increased fluorescence is detected. The cycle number 
that yields a fluorescence intensity significantly above background levels is designated as 
the threshold cycle (CT). CT is inversely proportional to the logarithmic of the copy 
number of the target sequence in the input D N A . (Fig. 2). To normalize for cell 
equivalents in the input D N A , we used a separate real-time PCR/molecular beacon assay 
to quantify the CCR5 coding sequence, since it is known that this gene is present at 
exactly two copies per cell, with no pseudogenes (L. Kostrikis, personal communication). 
Human al T R E C were detected in great abundance (~105 copies/106 cells) in fetal 
thymic tissue, but were undetectable in non-lymphoid tissue or immortalized cell lines. 
al T R E C were enriched in naive (CD45RA+CD62L+) subpopulations of peripheral C D 4 
and C D 8 cells compared to memory (CD45RO+) subpopulations. In a study of 532 
normal persons, we found that al TREC are high in the first 10-15 years of life, followed 
by a sharp drop between the ages of 15 and 20, and a gradual decline thereafter. 
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Compared with age-matched uninfected controls, most HIV-1 infected patients had 
normal al T R E C numbers, while a subset had reduced numbers. Interestingly, after 
receiving H A A R T , patients with a pre-existing impairment in al T R E C numbers 
exhibited a significant increase, whereas those with normal baseline al T R E C showed no 
change with treatment 17). 
5.1.3 Development of a Real-Time PCR/Molecular Beacon Assay to Quantify 
al T R E C in Rhesus Macaques In order to use T R E C as a marker for R T E in further 
studies, the corresponding region of the al T R E C was amplified and sequenced in rhesus 
macaques. (Fig. 3). As the primer sequences designed to detect the al T R E C in humans 
did not demonstrate 100% homology with those of macaques, new primers 
were designed to amplify a 183 base pair region. Thermal profiles of the human al 
T R E C beacon revealed that a single base pair change in the macaque target sequence 
resulted in a 1 0 % decrease in binding at the assay annealing temperature. A new beacon 
was designed for the macaque target sequence. (Fig. 4). 
No sequence variation was observed in the beacon target site for the CCR5 gene 
between humans and macaques. The appropriate base pair substitutions were made in the 
CCR5 primer sequences to adapt the primers for macaques. 
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Figure 2. Threshold cycle is inversely proportional to the log of the input copy number. 
Human GGATGGAAAAC^CAGTGTGACAHHaGGGCTGAACTT ATT*. CAACTC| 
R2 09 GGATGGAAAACACAGTGTGACATGGAGGGCTGAA TT',TCAnv.CAAC] 
R2 5 8 GGATGGAAAACACAGTGTGACATGGAGGGCTGAA TT* •; rCATTACAACl 
R104 M I^^A^^^SRtGTGACA'iBa.GGGCTGAACTT', T- ATTACAACTlCTGAGJ - ' 
R105 IpATGGJ^^^^ffiTGTGACATGgAGGGCTGAACTTGT'' ATTACAAC'lB'l'GJ"""* 
********************************** ** *** +X*********** ** 
Human TGAATGAAGAGCAGACAGGGCCC TGCCAGCTGCAGGGTTTAGGCACGGGGTGCAGGTGC 
R2 09 'I'i IAAT( AAGAGCAGACAGG|CCC TGCCAGCTGCAGGGTTTAGGCAAGGGGTGCAGGTGC 
R2 5 8 iGAATGAAGAGCAGACAGGlCCC TGCCAGCTGCAGGGTTTAGGCAAGGGGTGCAGGTGC 
RIO4 TGAATGAAGAGCAGACAGGlCCC TGCCAGCTGCAGGGTTTAGGCACGGGGTGCAGGTGC 
RIO5 iGAATGAAGAGCAGACAGGlCCC TGCCAGCTGCAGGGTTTAGGCACGGGGTGCAGGTGC 
*********************** ************************************ 
Human CT; T CATCACCGTG CACAGGAGTG. GCACCTTTACAAAAACGAGAGGTG 
R2 0 9 CT T . CATCACCGTG CACAGGAGTG GCACCTTTACAAAAACCAGAG 
R258 CTGTGCATCACCGTG ^CAGGAGTGAGCACCTTTlpAAAAACCAG. A'";< 
RIO4 CTGTGCATCACCGTGGGG GTC-BEAGGAGTGAGCACCTTTRAAi \CCAGAGG G 
RIO 5 CTGTGCATCACCGTG ij^ BAfififlGTGi .GCACCTTTACAAAAACgaGAflflJ 
** * ********** ********** ********************** * 
Human TCAGCATGGTTGAAaM^TGTGGCATCACCTTTGT!HHB 
R2 0 9 TCAGCATGGTTGAAaGGGATGTGGCATCACCTTTGTTGACAG 
R2 5 8 TCAGCATGGTTGAAAGGGATGTGGCATCACCTTTGTTGACAG 
RI0 4 TCAGCATGGTTGAACGGGATGTGGCATCACCTTTGTTGACAG 
RI0 5 TCAGCATGGTTGAAAGGGATGTGGCATCACCTTTGTTGACAG 
************** *************************** 
Re combination Signal Sequence 1 
Recombination Signal Sequence 2 
ico'JU^ d" y e t"jfij 
|imer Target S i J 
Figure 3. Comparison of al TREC sequences from human and rhesus macaque 
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Figure 4. al T R E C beacon binding specificity 
5.1.4 Generation of D N A Standards for Real-Time P C R Assays An internal 
standard is used on all runs of real-time PCR, ranging from lxl07to 10 copies. Internal 
standards can be compared to an external standard curve resulting from a minimum of 6 
replicates to validate individual runs. Initially these assays were developed with optical-
density quantified PCR product standards, however these standards demonstrated an 
inherent instability and were abandoned in favor of plasmid standards containing the PCR 
amplicon of interest cloned into a T/A cloning vector (Invitrogen, Carlsbad, CA). 
Competent cells (Invitrogen) were transformed with this plasmid and grown to large 
quantities. Plasmid was purified using the Wizard Miniprep kit (Promega) and quantified 
by O.D. Amplicons were confirmed by sequence analysis. 
Plasmid standards were more stable than PCR product; however, the means of 
quantifying plasmid and calculating copy number using the molecular weight of the 
plasmid was not as accurate as was desirable, and the plasmid standards were found to be 
sensitive to multiple rounds of freeze-thaw. W e turned to M13 bacteriophage as the 
optimal strategy for generating a stable and accurately quantified D N A standard. 
The PCR product of interest was generated and cloned into Ml3 bacteriophage by 
blunt-ended ligation. Standards were confirmed by sequence analysis. Viral titers were 
calculated from plaque generation and copy number was calculated. Phage standards 
were found to be stable under a variety of conditions, and copy numbers were deemed 
sufficiently accurate for this assay system. 
External standard curves were generated for each assay using a minimum of six 
replicates ranging from 2.5xl06 to 2.5x10'. These curves are shown in Figure 5. As the 
phage is single stranded, one particle corresponds to 0.5 double-stranded D N A copies in 
the real-time PCR assay. Each PCR plate contained duplicate internal standards in the 
same range, and these were compared to the external standard curve to validate the run 
and check for standard degradation. Phage standards were stable at 4°C, although stocks 
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Figure 5. M13 phage external standard curves for real-time PCR of al TREC and 
CC R 5 . Standard curve equation for al TREC: y= -1.7637Ln(x) + 44.414, R2 = 0.9966. 
Standard curve equation for CCR5: y= -1.4372Ln(x) + 42.146, R2 = 0.9982. 
5.1.5 Age Distribution of al T R E C in Normal Macaques al T R E C values 
were measured in P B M C of 96 normal rhesus macaques ranging in age from 1.4 to 5.6 
years (Fig. 6). The average al T R E C value for rhesus macaques of ages 1-4 was 
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1.98xl04/106 P B M C . The median al T R E C value was 6.18xl03/106 P B M C . There was 
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Figure 6. Age distribution of al TREC in normal rhesus macaques. (n=96) 
Age 1-2 n=44, 2-3 n=25, 2-4 n=l6. 4-5 n=4, 5-6 n=7. Mean of ages l-t = l.98xl04, median of 
ages I^ = 6.l8xl03. 
A small number of animals (n=6) had concentrations of greater than 1 0 % al 
T R E C bearing P B M C . These values seem quite high, particularly as the average 
concentration of al T R E C bearing cells in the thymus is slightly less than 1 0 % 
(discussed below). W e believe T R E C concentrations in the periphery to be lower than 
concentrations in the thymus, however we do not have thymic tissue from these animals 
to compare to the P B M C . Longitudinal studies of individual animals, rather than a single 
'snapshot' sample, would give more valuable information in terms of inter-animal 
variation. 
These values may also be overestimated due to processes occurring in P B M C that 
alter the T cell to non-T cell ratio. These six animals may have unusually high 
percentages of T cells among their P B M C at this time point, creating an artificially high 
concentration of al TREC bearing cells. This is one of the flaws of using P B M C as a 
denominator of al T R E C calculations; more valuable data would be obtained from 
studying sorted T cells. While initial studies in this area used P B M C as a readily 
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obtainable population to examine, future studies will need to focus on sorted T cell 
populations. 
5.1.6 al TREC in the Thymus of Juvenile and Neonatal Macaques Figure 7 
shows the concentration of al T R E C in the thymocytes of ten juvenile macaques (age 2) 
and three neonatal macaques (ages 6-8 weeks). Tissue was obtained from two normal 
juvenile macaques at necropsy, the other samples were collected from surgical 
thymectomy at the start of this study. The mean concentration of al TREC in the thymus 
of juvenile macaques was 9.1xl04/106 thymocytes, or 9.1%. Values ranged from 5.5xl04 
to 2.01xl05/106 thymocytes. The mean concentration of al T R E C in the thymus of 
neonatal macaques was 6.28xl04/106 thymocytes, or 6.28%, with values ranging from 
4.88xl04 to 7.51xl04/106 thymocytes. 
To better define the concentration of al T R E C bearing cells at various stages of 
thymocyte development, juvenile macaque thymuses were stained and sorted for 
CD3+CD4+CD8+ (double positive, DP), CD3+CD4+ (single positive CD4), and CD3+CD8+ 
(single positive, CD8) subsets (Fig. 7b). The mean concentrations in single positive 
C D 4 and CDS were 11.14% and 11.12% thymocytes bearing al TREC, respectively. 
These values are similar to the reported concentration of 1 0 % of al TREC bearing cells 
in sorted CD45RA+CD62L+ naive cells in humans(198). These values will also be 
crucial to the thymic output calculations discussed below, as they will serve as a means of 
calculating the absolute thymic output from the measured output of al TREC bearing 
cells. 
The percentage of al T R E C bearing cells might be expected to be higher in the 
double positive stage of thymocyte development, where T C R a recombination takes 
place. In fact, the mean concentration in double positive thymocytes was 10.19%. This 
value is reasonable when one takes into account the fact that the majority of cells in the 
double positive stage of development have already undergone recombination followed by 
one or more rounds of division, and that those having divided greatly outnumber those 
recombining. If the al recombination event occurs in 7 0 % of TCR5 deletion 
recombination events, as reported previously(169), we can estimate that 7 0 % of actively 
recombining D P thymocytes contain the al T R E C before division, 3 5 % contain the al 
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T R E C after 1 round of division, 17.5% after two rounds, 8.75% after 3, and so on. 
Assuming cell death occurs randomly at each round of division, the weighted average of 
the cells in various stages of the double positive subset would yield an overall average of 
18.6% with 3 rounds of replication, 11.3% with four rounds, and 6.6% with five rounds 
of replication. Our data would thus support an average of 4 divisions between T C R a 
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Figure 7. al T R E C concentrations in the thymus. Hatched bars indicate juvenile 
macaques at necropsy, dark bars indicate juvenile macaques at thymectomy, and light 
bars indicate neonatal macaques at thymectomy. M e a n for juvenile macaques: 9. lxlO4, 

















Figure 7b. % of al TREC bearing cells among thymocyte subsets. Mean for double 
positive: 10.93%, mean for single positive CD4: 11.14%, mean for single positive CD8: 
11.12%. 
5.1.7 Distribution of al T R E C in Lymphoid Tissues of Two Normal Juvenile 
Macaques al T R E C values were measured in multiple lymphoid tissues of two juvenile 
macaques at necropsy (Fig. 8). al T R E C were measured to be approximately lxl04/106 
P B M C in these animals, well within the normal range for juveniles of the same age. The 
al T R E C concentration was tenfold higher in the thymus of animal AR86 and twentyfold 
higher in the thymus of AT89, corresponding to 10 and 2 0 % of thymocytes, respectively 
(also shown in Fig. 7). 
al T R E C concentrations in the lymph nodes ranged from values similar to those 
measured in P B M C up to values fourfold higher. There was a considerable variety in 
T R E C concentrations among different lymph nodes in the same animal. Intestinal 
intraepithelial lymphocytes and lamina propria lymphocytes from the ileum, jejunum, and 




















Figure 8. Tissue distribution of al T R E C in two normal juvenile rhesus macaques. 
5.2 Thymectomy 
5.2.1 Surgical Removal of the Thymus Nine animals were selected for 
thymectomy and eight for sham surgery. Animals were anesthetized and surgery 
performed as described above. The thymus of the juvenile macaque has a thoracic portion 
which is easily identified, and a cervical portion which extends up into the neck. The 
organ is readily distinguished from surrounding fat and is encapsulated, which allows for 
ease of removal. Visual inspection at the time of surgery indicated that thymectomy was 
complete, and this was later confirmed on necropsy in the animals which were sacrificed. 
5.2.2 Effect of Thymectomy on CD3, CD4, and CD8 T Cell Counts Absolute 
T lymphocyte counts were measured at multiple time points for three hundred days 
following thymectomy (Fig. 9a) and sham surgery (Fig. 9b). Thymectomy had no 
observable effect on absolute T cell counts, a result which is expected from analogy to 
clinical scenarios involving thymectomy in children. Slopes were calculated for CD3+, 
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CD4+, and CD8+ T cells in each animal and are shown in Table 2. A comparison of these 
slopes demonstrated no statistically significant difference in T cell decay between the two 
groups (p value for CD3+= 0.3865, CD4+= 0.1489, CD8+= >.9999, obtained by Mann-
Whitney U test). Similarly, there were no observable changes in the percentages of CD3+, 
CD4+, or CD8+ lymphocytes after thymectomy, despite minor fluctuations in both groups 
(Fig. 10a-10b). 
5.2.3 Effect of Thymectomy on Naive T Cells There were no overall changes in 
the percentages of CD45RA4 cells within CD3+, CD3+CD4+, and CD3+CD8+ lymphocytes 
following surgery (Fig. lla-llb), although some animals of both groups show 
considerable fluctuation in naive cell percentages from month to month. 
Because absolute CD45RA+ naive T cell counts were obtained by multiplying the 
percentage of CD45RA+cells within any T cell subset and the absolute count of that 
subset, absolute naive T cell counts largely reflect the patterns seen in the absolute CD3+, 
CD4+, and CD8+ T cells counts. Despite any transient fluctuation in naive cell 
percentages, there was no significant decline in total CD45RA+naive T cell counts (Fig. 
12a-12b). 
Slopes were calculated for CD3+CD45RA+, CD4+CD45RA+, and CD8+CD45RA^ 
and are shown in Table 3. There was no statistically significant difference in naive T cell 
decay slopes between the two groups (p value for CD3+CD45RA+= 0.5006, 
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5.2.4 T Cell Proliferation Post Surgery Based on the observation that 
thymectomy results in little quantitative change, if any, in the phenotypic makeup of the 
peripheral T cell pool, we wanted to address the question of whether peripheral 
proliferation of T cells was increased to fill the niche in the absence of the thymus. W e 
used the nuclear antigen Ki67 as a marker for cell division(92). Figure 13 shows the 
percentages of Ki67+ CD3+CD4+ and CD3+CD8+ T cells measured post thymectomy. The 
percentages of proliferating T cells did not change significantly during the course of the 
study, and are overlapping at all time points between the thymectomized and sham group. 
Moreover, the range of proliferating cells (1-7% of CD3+CD4+ and 1-9% of CD3+CD8+) 
is within the normal range for rhesus macaques(191). W e can conclude from this that 











r M T 






T T ^ 
CD3+CD4+ 

















2 3 4 7 8 10 2 3 4 7 8 10 
Month Post Surgery 
Figure 13. %Ki6T CD3+CD4+ and CD3+CD8+ T cells post thymectomy. Shaded 
boxes indicate thymectomized animals, open boxes represent sham animals. 
5.2.5 Thymectomy Results in a Decline in al T R E C Bearing T cells At 
baseline, the P B M C al T R E C values of the nine animals assigned to the thymectomy 
54 
group and the eight animals assigned to the sham group were evenly matched (Fig. 14a). 
The median for the thymectomy group was 2.17xl04/106 P B M C , whereas the median for 
the sham group was 1.99xl04/106 P B M C (p value: 0.8474 by Mann-Whitney U test). Ten 
months post surgery, the two groups had significantly different al T R E C values (Fig. 
14b). The median for the thymectomy group had decreased nearly one log to 
3.49xl03/106 P B M C , while the median for the sham group was largely unchanged at 
1.43xl04/106 P B M C (p value: 0.0005 by Mann-Whitney U test), indicating a significant 






















Baseline 10 Months Post Surgery 
Figure 14. al TREC/106 P B M C at baseline and 10 months post surgery. Shaded 
boxes indicate thymectomized animals (n=9), open boxes represent sham animals 
(n=8). p value at baseline: 0.8474. p value at 10 months post surgery: 0.0005. 
Figure 15 shows boxplots of al T R E C decline in P B M C , CD4+, and CD8+ T cells 
after thymectomy. (For detailed plots of individual animals, see Appendix 1). While the 
concentration of al T R E C positive cells in the P B M C of thymectomized animals 
declined after surgery, a comparison of the slopes between the two sets of animals was on 
the borderline of statistical significance (Table 4, p value= 0.0543 by Mann-Whitney U 
test). However, it was a concern that the effect of thymectomy on the al T R E C positive 
concentrations in P B M C might be diluted by non-T cells in the population studied, so w e 
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analyzed al T R E C concentrations in sorted CD4+ and CD8+ T cells. As expected, al 
T R E C decay in these T cell subsets was significantly increased by thymectomy (Table 4, 
p value for CD4+= 0.0015, CD8+= 0.0005). The average slopes correspond to a half-life 
of 129 days for al T R E C in P B M C in the thymectomized macaques as compared to 561 
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Figure 15. al TREC/106 PBMC, CD4, and CD8 post surgery. 
A, C, and E: Thymectomized macaques. B, D, and F: Sham controls. 























































































Table 5. al T R E C decay post thymectomy 
P B M C 
C D 4 
C D 8 














5.2.6 Calculation of Thymic Export Rates in the Juvenile Rhesus Macaque 
The decay slope of al T R E C positive P B M C was calculated to be 0.0054 day"1, or 0.5% 
of al T R E C bearing cells per day. W e can conclude that this decay rate is the output rate, 
or source, of 0.5% of al T R E C bearing cells per day. 
Given the median al T R E C levels in both groups at baseline, and taking into 
account the fact that any one cell can contain either one or two al TREC depending on 
recombination on each chromosome, we can calculate a range of 1.1-2.2% of total T cells 
that are al T R E C positive. 
Based on the assumption that the average macaque has 10u total T cells and that 
al T R E C are evenly distributed, we can calculate an absolute range of total T cells that 
are al T R E C positive, l.l-2.2xl09 0.5% of this total yields an absolute thymic 
production rate of 5.5xl06 -l.lxlO7 al T R E C bearing cells per day (Fig. 16), a minor 
fraction of the total T cell pool. 
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Figure 16. Calculation of an absolute thymic export rate. 
The change in al T R E C over time is equal to the input source minus proliferation 
and death, or 
dTREC/dt = s-trec- (Ptoec+cW) (D 
In our system, where s' is the source after thymectomy (assumed to be zero), 
s'(~0) - (Prac+cW) = -0.0054/d (2a) 
s'(~0) + 0.0054/d = PTREc+dxREc (2b) 
From this we see that 0.0054/d is a minimum estimate of source. Should s' be 
greater than 0, the actual source would be greater. Although residual thymic tissue was 
not detected on necropsy, even with a conservative assumption that the thymectomy was 
only 50% complete, the doubled thymic production rate, l.l-2.2xl07, is still a miniscule 
fraction of the total T cell pool. 
There is a very low rate of al TREC decay in the PBMC of the sham animals as 
well, -0.0012/d. Adjusting the decay rate in the thymectomized animals for this 
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presumably age-related decline gives us a rate of -0.0042/d, or 0.4% of al TREC bearing 
cells per day, which translates to an even smaller output of 4.4-8.8xl06 al TREC bearing 
cells per day. 
Using our measured concentrations of al T R E C bearing cells among single 
positive thymocytes, it is possible to estimate a total thymic export rate. As only 11% of 
single positive thymocytes are al T R E C bearing cells, we must correct our 
measurements of al T R E C bearing cell export by a factor of 11. This yields a total 
thymic export rate range of 6.1xl07 - 1.2xl08. 
5.3 Infection 
5.3.1 Viral Loads and Disease Progression Approximately three hundred days 
after surgery, six thymectomized and six sham macaques were inoculated with 100AID50 
(animal infectious dose) of SIVMAC251. Plasma viral loads are shown in Figure 17. Viral 
loads peaked at fourteen days post infection in both thymectomy and sham groups. The 
viral load plateau, or setpoint, was reached by day 89 in both groups. There was no 
statistically significant difference in peak viral load or average viral load at setpoint 
between the two groups (Fig. 18, p= 0.0547 for peak viral load, p= 0.7488 for setpoint by 
Mann-Whitney U test). 
Within 200 days of infection, four thymectomized animals and two sham animals 
showed evidence of simian acquired immune deficiency syndrome (SAIDS) and 
opportunistic infections and were sacrificed. By 300 days post infection, a third sham 
animal had been sacrificed. Gross necropsy findings are reported in Table 6, and all 
findings were consistent with SAIDS. Viral load was a prognostic indicator in both 
thymectomy and sham groups. While some might argue that progression to disease 
appears to be faster among thymectomized animals, the small number of animals in 
each group makes it impossible to determine whether this is an effect of thymectomy or 
of individual response to pathogenesis. Death within six months to one year, one of the 
hallmarks of rapid progression in SIV, would be expected in this number of animals in 
either group, and would be predicted by high viral loads, as was observed. The absence 
of antibody response would confirm rapid progressor status in these animals. A study of 
61 
a larger cohort of animals would be necessary to determine whether thymectomy has an 
influence on rapid progression to disease and death. 
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Figure 17. SIV viral loads A. Thymectomized macaques. B. Sham controls. 
Red circles indicate development of simian AIDS and sacrifice. Animal AI73, marked with 






Peak Viral Load Viral Setpoint 
Figure 18. Boxplots of peak viral load and viral setpoint Light shaded boxes represent 
thymectomized animals, dark shaded boxes represent sham animals, p value of peak viral 
load: 0.0547. p value of setpoint: 0.7488. 


















Chronic pneumonia.. Severe diffuse SIV pneumonia. Severe disseminated. 
M . swima infection. Pneumococcus cultured from the lung\ Multifocal 
mild SIV encephalitis. 
Chronic pneumonia. Lesions of jevere diffuse interstitial pneumonia with 
multinucleated giant cells and severe Pneumocystis carinii. 
Severe disseminated M . avium infection affecting' the intestinal tract, tone 
marrow, and lymphoid tissues. SIV pneumonia and encephalitis also 
observed. 
Chronic pneumonia. Severe interstitial giant cell pneumonia.. 
Disseminated M . avium infection. Pneumococcus cultured from the lung\ 
Cytomegaloviral pneumonia and intestinal cryptosporidiosis. SIV 
encephalitis and generalized giant cell disease. Acute myocarditis without 
inclusion bodies, possibly secondary to C M V . 
Viral interstitial pneumonia. Chronic gastritis. Localized amyloidosis 
in the small intestine. 
Pneumonia.. Pathology report pending. 
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5.3.2 Effect of Infection on CD4+ T Cell Counts After infection, the absolute 
CD4+ T cell counts in the thymectomized animals began to decline (Fig. 19aA). Among 
the sham group, two of the infected animals, AI04 and AL15, had an observable drop in 
CD4/fu1, but the others did not (Fig. 19bA). A comparison of the C D 4 decline between 
preinfection and postinfection values indicated that the drop after infection was 
significant among the thymectomized animals (p= 0.0104, Table 7) but not among the 
sham controls (p= 0.7488). Uninfected macaques in both groups showed no overall CD4 
decline (Figs. 19aB, 18bB, Table 7). 
A comparison of the infected thymectomized and sham animals revealed that 
there was no statistical significance in the C D 4 decay slopes between the two groups (p= 
0.2002 (Table 8)). Although high viral load was associated with death within this study 
period, the animals with lower viral loads had lower C D 4 counts. 
The percentage of lymphocytes that were CD4+ also declined after infection in the 
thymectomized and some of the sham macaques, mirroring the decline in absolute C D 4 
counts (Fig. 20aA, 20bA). Again, uninfected controls had no change in the relative 
lymphocyte populations (Fig. 20aB, 20bB). 
5.3.3 Effect of Infection on CD8+ T Cell Counts The impact of infection on the 
absolute CD8+ T cell counts in these animals varied. Among thymectomized animals, 
there was a decline in CD8/u,l with transient increases that may reflect antigen-stimulated 
proliferation (Fig. 19aA). Among sham animals, two animals, AI04 and AL15, had a 
decline in CD8/ixl that mirrored their decline in CD4/ii.l, while the others had sustained or 
slightly increased C D 8 counts (Fig. 19bA). The overall C D 8 trends were not 
significantly different from those preceding infection in either thymectomized or sham 
animals (p= 0.6310 for thymectomy, 0.7488 for sham (Table 7)). Uninfected macaques in 
both groups showed no overall C D 8 decline (Figs. 19aB, 19bB, Table 7). There was no 
statistical significance in the C D 8 slopes between the infected animals of the 
thymectomized and sham groups (p >0.9999 (Table 8)). 
The changes in the percentage of lymphocytes that were CD8+ also varied from 
animal to animal. In the thymectomy group, many of the animals had a steady increase in 
the percentage of CD8+T cells, while others had very little change. One animal, AI25, 
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had a period of dramatic increase that was temporally correlated with the transient 
increase in absolute C D 8 count (Fig. 20aA). In the sham group, only one animal, AK67, 
had a steady increase in the percentage of CD8+ T cells, while the others had relatively 
steady values (Fig. 20bA). Uninfected animals of both groups had no change in the 
relative lymphocyte populations (Fig. 20aB, 20bB). 
5.3.4 CD4:CD8 Ratios After Infection After infection, the CD4:CD8 ratio in 
both thymectomized and sham animals dropped sharply, with all animals reversing the 
CD4:8 ratio (less than 1.0) by twenty-eight days post infection (Figs. 21aA, 21bA). One 
sham animal, AK67, seemed to have a rebound in CD4:8 ratio after 100 days post 
inoculation, but this was revealed to be secondary to a rapid drop in absolute CD8 count 
in the time points preceding death. In contrast, uninfected animals in both the 
thymectomized and sham groups had a stable CD4:8 ratio in this time period, at normal 
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5.3.5 Effect of Infection on Naive T Cells Despite minor fluctuations in the 
percentages of CD45RA+ cells in the CD3+, C D 4 \ and CD8+ populations of the infected 
animals, the overall proportion of naive cells remained unchanged, and fairly high (Figs. 
22aA, 22bA). In uninfected macaques of both groups, the proportion of naive cells was 
also stable (Figs. 22aB, 22bB). 
As the percentage of naive cells was relatively stable throughout this period, the absolute 
CD45RA+ cell counts in each T cell subset was reflective of the changes in absolute 
CD3+, CD4+, and CD8+ populations (Figs. 23a, 23b). In all of the infected animals of the 
thymectomy group, there was a decline of naive CD4+ T cells that was not significantly 
steeper than before infection (p=0.0782 (Table 9)). In the infected sham animals, there 
was no significant difference in the decay of naive CD4+ T cells (p= 0.5218). There was 
no significant difference between the naive C D 4 decay between infected thymectomy and 
infected sham animals (p= 0.3367 (Table 10)). There was no change in the uninfected 
macaques during this period (Figs. 23aB, 23bB, Table 9). 
The overall absolute number of naive CD8+T cells was also stable during the 
period after infection. There was no significant decay as compared to the preinfection 
values in both the thymectomy and sham groups (p= 0.1495 for thymectomy, 0.2623 for 
sham (Table 9)). Neither was there any difference between the infected animals of the 
two groups (p >0.9999 (Table 10)). There was no change in the uninfected macaques 
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5.3.6 Effect of Infection on T Cell Proliferation Figure 24 shows the effect of 
SIV infection on the percentages of Ki67+ cells in the CD3+CD4+ and CD3+CD8+ 
populations. In the infected macaques of the thymectomy group, the percentage of Ki67+ 
CD3+CD4+ T cells remained in the normal range, below 10%, until 16 weeks post 
infection, at which point the percentage of proliferating C D 4 T cells began to increase, 
reaching a mean of 9.3% by week 24 post infection. Infected macaques of the sham 
group also showed a slight increase in the percentage of Ki67+ CD3+CD4+ T cells, but 
with few exceptions the values remained below 10%, reaching a mean of 3.9% at week 
24 post infection. Uninfected macaques of both groups remained below 10% at all time 
points, with a few outlying points(192, 193). 
In contrast, there was an immediate increase in the percentages of proliferating 
CD8+ T cells by week 2 post infection, reaching a mean of 24.9% in thymectomized 
animals and 2 0 % in sham animals. This increase, no doubt due to antigen-stimulated 
proliferation of CD8+ T cells, was followed by a decline in the percentage of Ki67+ 
CD3+CD8+ T cells. Towards the later weeks of infection there was a second wave of 
increased Ki67+ CD3+CD8+ T cells, reaching a mean of 18.2% in the thymectomy group 
by week 24. The sham group did not have this second wave of increase, and the mean 
was 6.4% by week 24. Uninfected macaques of both groups remained in the normal 
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5.3.7 al T R E C Decay Following Infection Figure 25, 26, and 27 show the 
changes in al T R E C in the P B M C , CD4, and C D 8 T cells, respectively, during this 
study. (For detailed plots of individual animals, see Appendix 2). The al TREC decay 
following thymectomy is shown in A and D, and the changes following infection are 
shown in B and E. Uninfected controls are represented in C and D. 
Infection significantly increased the decay of al T R E C in P B M C in both the 
thymectomy and the sham groups (p= 0.0250 for both groups by Mann-Whitney U test) 
(Fig. 25B, 25E, Table 11). Uninfected control animals had al T R E C decay slopes 
comparable to those in the period before infection (Fig. 25C, 25F, Table 11). 
In the sorted C D 4 population, al T R E C decay increased after infection in both 
the thymectomy and sham groups (p= .0062 for thymectomy, 0.0374 for sham) (Fig. 
26B, 26E, Table 11). In the sorted C D 8 population, al T R E C decay increased after 
infection in both the thymectomy and sham groups, but surprisingly, only the sham group 
had a significant difference from the preinfection slope (p= 0.2012 for thymectomy, 
0.0104 for sham) (Fig. 27B, 27E, Table 11). 
The average slopes presented in Table 11 reveal that the thymectomized animals 
had a faster decline of al TREC than sham animals after infection. However, to compare 
the al T R E C decay between the infected thymectomized and infected sham animals, it 
was necessary to adjust the slopes for the preexisting impairment resulting from 
thymectomy. This was done by subtracting the preinfection slope from the postinfection 
slope for each individual. Adjusted slopes, presented in Table 12, reveal no significant 
difference in the slope of al TREC decay between thymectomized and sham animals (p= 
0.7488 for CD3, 0.0679 for CD4, and 0.2733 for CD8). This indicates that infection had 
comparable impact on the al T R E C decay in thymectomized and euthymic animals, and 
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5.4.1 Distribution of al TREC in Lymphoid Tissues Post Thymectomy, 
Before Infection Eight months after the surgery, four thymectomized and two sham 
macaques underwent tissue biopsy of multiple sites reported to be possible extrathymic 
sources of T cells (Fig. 28). The profile in the two control macaques was similar to that 
of the two normal juveniles presented in Figure 8, with an average al T R E C 
concentration of 1.6% in P B M C , 2.2% of colonic lymph node, 0.8% of liver, and less 
than 0.6% of intestinal lymphocytes. 
While overall al T R E C concentrations were roughly twofold lower in the 
thymectomized macaques, the relative pattern was the same. The average al TREC 
concentration was 0.7% of P B M C , 1% of colonic lymph node, 0.3% of liver, and less 
than 0.15% of intestinal lymphocytes. This suggests that the decrease in al TREC in the 
peripheral blood of thymectomized macaques is reflected in an overall decrease in 
lymphoid tissues, and that none of the tissues surveyed displayed a compensatory 
increase in al T R E C as would be expected in an alternate source. 
5.4.2 Impact of SIV Infection on al TREC in the Lymph Nodes To assess the 
impact of SIV infection on the concentration of al T R E C bearing cells in the lymph 
nodes, biopsies were taken two and nine weeks post inoculation. These data are 
presented in Figure 29, along with preinfection biopsy data and necropsy data from those 
animals that have expired. 
At the time of inoculation, thymectomized animals had a lower concentration of 
al T R E C bearing cells in the lymph nodes than sham controls. After infection, both 
thymectomized and sham macaques had a similar decrease in al TREC concentration in 
the lymph nodes. By nine weeks post inoculation, the average al TREC concentration in 
lymph nodes dropped almost one log, from l.lxl04/106 lymphocytes at the preinfection 
time point to 2.7xl03/106 lymphocytes. The sham controls also dropped from 2.4xl04/106 
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Figure 28. Tissue distribution of al T R E C eight months post thymectomy. Light shaded 
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Figure 29. al TREC in Lymph Nodes Pre and Post Infection. Each bar represents the 
average of single biopsies from one or more animals. Necropsies include multiple lymph 
nodes from each animal. All animals involved in the study were biopsied at 2 and 9 weeks 
post inoculation (n=2-6 for various groups). Preinfection biopsies n=l-3, necropsy n=2-4. 
The uninfected animals in both the thymectomy and sham group did not have the 
same dramatic decline in lymph node al T R E C . The uninfected animals of the 
thymectomy group had a slight drop from 8.4x1 (jVlO6 at the preinoculation time point to 
SSxttf/lO6 at the nine-week point. In contrast, the uninfected animals of the sham group 
had an increase in lymph node al T R E C from 1.9xl04/106 to 3xl04/106 during this time 
period. 
5.4.3 Tissue Distribution of al TREC at Necropsy By six months post 
infection, four thymectomized and two sham macaques had expired from simian AIDS. 
al T R E C concentrations in the tissues of these macaques are presented in Figure 30. 
Thymectomized macaques had lower concentrations of al T R E C than sham controls in 
every tissue, but both groups had significantly lower concentrations than normal. The 
92 
average al T R E C concentration in the lymph nodes was 2.5xl03/106 in thymectomized 
animals, 5.7xlOVl06 in sham animals. 
The most striking difference between the thymectomized and sham animals was 
in the spleen, where the al T R E C concentration in sham animals was 1.8xl04/106 cells, 
nearly two logs higher than the concentration in thymectomized animals, 6.2xl02/106. 
Values obtained from the sham animals are very close to the value obtained from one 
uninfected macaque spleen, 1.28xl04/106 cells (data not shown). 
By the time of death, al T R E C bearing intestinal lymphocytes were virtually 
undetectable in both groups, probably reflective of an overall loss of lymphocytes in the 
gut. 
Thymic tissue was obtained from one sham macaque at necropsy. The 
concentration of al T R E C in the thymus was 3.33xl04/106 thymocytes, threefold lower 
than the average normal concentration of 9.1xl04/106. This was reflected in the 
disruption of the architecture of the thymus of the same macaque (Fig. 31). Thymic 











































































Figure 30. Tissue distribution of al TREC at necropsy. Light shaded columns indicate 
thymectomized macaques (n=4, n=2 for intestinal lymphocytes), dark columns indicate sham 
macaques (n=2) 
5.4.4 al T R E C in the Tissues: S u m m a r y Table 13 shows a summary of al 
T R E C concentrations in the tissues expressed as the percentage of al T R E C bearing 
cells. Overall, these studies indicate that thymectomy results in a decrease of al T R E C 
in the lymphoid tissues. This decrease reflects that seen in the peripheral blood of 
thymectomized macaques, indicating that there may be circulation of al T R E C bearing 
cells, rather than compartmentalization in sites protected from the effects of thymectomy. 
SIV infection also causes a decrease in the al T R E C bearing cells in the lymphoid 
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1.41 to 1.81 
1.96 to 2.45 
0.27 to 1.41 
0.20 to 0.49 
0.30 to 1.07 
0.38 to 0.41 
0.29 to 0.87 
Range 
0.38 to 0.52 
0.17 to 0.92 
0.50 to 3.13 
0.02 to 0.23 
0.00 to 0.03 
0.00 to 0.09 
0.01 to 0.22 
5.5 T C R p C D R 3 Profile The quantity of peripheral T cells did not decrease 
appreciably following thymectomy. However, these data do not yield any information 
about the quality of the immune panel after surgery. Therefore, we used TCR (3 CDR3 
length polymorphism as an indicator of the diversity of the T C R repertoire among the 
P B M C of representative thymectomized and sham animals. 
Twenty-five V(3 families were studied, and Fig. 32 shows the qualitative changes 
in one representative V(3 family from each of four macaques over the course of this study. 
The four animals chosen were AI25, thymectomized and infected, AH02, thymectomized 
and uninfected, API9, sham and infected, and BI25, sham and uninfected. 
The top panels indicate the profile at baseline, the middle panels indicate the 
profiles eight months post surgery, and the bottom panels indicate the profiles three 
months post infection. For the two animals that were not infected, AH02 and BI25, the 
three month post inoculation time point represents thirteen months post surgery. 
Genescan software was used to define the number of species in each VP family at 
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5.5.1 Thymectomy Results in Restriction of the T C R Repertoire Eight 
months post thymectomy, the V|3 profiles in both thymectomized and sham animals were 
virtually unchanged. Minor shifts in the relative frequencies of species within each 
family were observed in all animals, but the overall profile was of a broad, sustained 
polyclonal population with myriad species in all of the 25 V(3 families assayed (Fig. 32). 
However, by thirteen months post thymectomy, there was evidence of restriction 
in the immune panel in the uninfected thymectomized macaque AH02. While the sham 
control BI25 remained stable throughout this time period, AH02 showed evidence of 
oligoclonality within many, though not all, of the Vf3 families. 
This observation is confirmed by comparing the number of species within each 
Vf3 family (Table 14). Eight months post surgery, neither the number of species within 
each family nor the sum of species changed appreciably in the thymectomized animals 
AI25 and AH02. However, thirteen months post thymectomy, the number of species 
within many families of animal AH02 have decreased, and the sum of species is 4 0 % of 
the sum at baseline. The sham control BI25 showed no evidence of restriction during the 
thirteen month time period, ruling out age-related restriction as an explanation for this 
phenomenon. 
5.5.2 Infection Results in Dramatic Restriction of the TCR Repertoire Three 
months post infection, both thymectomized animal AI25 and sham animal AP19 showed 
evidence of dramatic restriction of the TCR repertoire. Visually this is evidenced by a 
dramatic shift from multiple peaks, or species, within each Vf3 family, to a single 
dominant species or a small number of species (Fig. 32). This is confirmed by the 
decrease in the number of species in each V(3 family, both in the thymectomized and the 
sham infected macaque (Table 14). 
In the sham infected macaque, AP19, the sum of species after infection was less 
that 6 0 % of that at baseline. This decrease, though remarkable, was nowhere near that 
observed in the thymectomized macaque AI25. After infection the sum of species in 
AI25 was 2 7 % of that at baseline. This suggests that there is a combined effect of 
thymectomy over the long term and the deleterious effect of SIV infection on the TCR 
repertoire in this animal. 
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6. Discussion 
6.1 Development of an Assay to Detect al T Cell Receptor Excisional Circles in the 
Rhesus Macaque The development of a PCR-based assay for the al T R E C enables the 
examination of a population of cells that can be defined as recent thymic emigrants, 
where 'recent' refers to the number of cell divisions since leaving the site of 
recombination, rather than the time elapsed. This assay, used in conjunction with other 
methods of defining phenotypically naive cells, allows a more refined examination of the 
effects of thymectomy than has previously been possible. 
It has been reported that adult thymectomy is not associated with immunological 
deficit(30-32, 53). This is consistent with multiple lines of evidence that both thymic 
mass and thymic output decline with age. However, initial studies using al TREC as a 
marker for thymic output in humans revealed that the thymus functions well into old 
age(16, 17). This raised the question of the significance of postnatal thymic output and 
its role in T cell homeostasis. 
While many studies on the role of the thymus in peripheral T cell homeostasis 
have been done on mice and sheep, the rhesus macaque model affords this study two 
benefits. The first is the evolutionary proximity of macaques to humans, and the second 
is the large body of work on infection of the rhesus macaque with SIV as a model for 
HIV-1 infection. W e thus sought to confirm observations made in the clinical setting 
using al T R E C as a marker for thymic output with a controlled animal study. 
The rhesus macaque model has some limitations compared to the mouse model. 
Large numbers of animals cannot be enrolled in a rhesus study, which limits the n values 
and thus the power of comparisons between experimental groups. The absence of 
congenic strains of rhesus results in a high level of inter-animal variation in many 
parameters, including normal values of T cells and al T R E C bearing cells as well as 
response to viral infection. Finally, there are restrictions on the amount of blood and 
tissue that can be obtained from rhesus macaques, limiting the scope of experiments that 
can be performed on the cohort. 
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The study of al T R E C has many benefits over previous methods for the study of 
thymic output. It is the first direct measure of recent thymic emigrants in mammalian 
species, fulfilling an experimental need in the absence of a cell-surface phenotypic 
marker. The PCR-based assay can be performed on up to eighty-four samples in under 
six hours, making it an efficient means of assessing thymic output in a large-scale study 
such as this one. The assay is sensitive down to 10 copies, dynamic within a 6-log range, 
and accurate (10% coefficient of variance)(17). The episome is stable in the cell(194) and 
thus lends itself to long-term studies of recent thymic emigrants, in contrast to fluorescent 
dye studies which are limited by the half-life of the dye within the cell. Finally, the assay 
can be used on stored samples, allowing retrospective studies of thymic output in various 
disease states. 
With these benefits also come drawbacks. The al T R E C is known to occur in 
- 7 0 % of the 5 locus deletion recombination events in humans(169). While this means 
that the al T R E C is a dominant species and readily measurable, an estimate of thymic 
output based on the al T R E C is based on a fraction of the total recombination events and 
is thus an underestimate of the total T cell production. Next, a study of cells bearing the 
al T R E C is limited to a(3 T cells. While these cells comprise the majority of cells 
released from the thymus, a study based on al T R E C does not take into account 
processes involving y& T cells. Finally, real-time PCR with molecular beacon assays 
require access to expensive reagents and equipment that is not yet common to all research 
facilities. 
An important consideration in the study of al T R E C is the cell population 
examined. While initial studies in the field focused on P B M C as the denominator for 
fraction of al T R E C bearing cells, it is more precise to examine al T R E C bearing cells 
as a fraction of total T cells or C D 4 and C D 8 subsets. This would control for variations 
in the T cell to non-T cell ratio among P B M C , which may skew concentrations of al 
T R E C bearing cells. 
The need for an assay to detect recent thymic emigrants in the peripheral blood 
and tissues far outweighs the limitations of the al T R E C as a marker for RTE. However, 
we must be cautioned against regarding al T R E C as a broad marker for thymic function, 
and focus instead on the specific population of a(3 T cells being studied. Like other assay 
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systems, this assay carries more weight in conjunction with other studies of peripheral T 
cell processes such as flow cytometry and TCR V(3 C D R 3 length polymorphism analysis. 
6.2 al TREC in the Normal Macaque Before beginning a study of the impact of 
thymectomy on the al T R E C population, it was necessary to understand the frequency 
and distribution of al T R E C in the normal macaque. W e began by measuring al TREC 
in the P B M C of 96 normal rhesus macaques, ranging in age from 1.4 to 5.6 years (Fig. 6). 
Mean and median al TREC value were calculated for animals between 1 and 4 years of 
age, as this was the age range of the macaques involved in the thymectomy study. The 
mean al T R E C concentration in macaques aged 1-4 years was 1.98xl04/106 P B M C , and 
the median was 6.18xl03/106 P B M C . 
There was an individual variation of up to two logs between animals within any 
age category. A similar degree of individual variation has been described in normal 
humans(17). As discussed above, this variation may be the result of skewing due to the 
use of P B M C rather than T cells as the denominator of the al T R E C calculation. A n 
ase-related curve could not be determined from this cohort as the number of animals 
above age four was small (n=ll), and samples from older macaques could not be 
obtained. A steep drop in al T R E C concentrations has been described in humans 
between the ages of 15 and 20(17). A corresponding drop in macaques would be 
expected to occur after six years of age. A future study of age-related decline in normal 
rhesus would benefit from evaluating al TREC in sorted CD3 T cells, and from access to 
a larger cohort of animals, particularly over the age of 6. 
It was expected that the concentrations of al TREC would be significantly higher 
in the thymus, where a locus recombination is taking place. Thymic tissue was obtained 
from ten juvenile and three neonatal macaques. The mean concentration of al TREC in 
the thymus of juvenile macaques was about 1 TREC in 10 cells, 9.1xl04/106 thymocytes 
(Fi^ 7). This value is nearly one log higher than the mean in the P B M C of macaques in 
the same age range. The mean concentration of al T R E C in the thymus of neonatal 
macaques was 6.28xl04/106 thymocytes, within the same range. This indicates that 
thymic recombination activity does not significantly decrease in the first years of life. 
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These values were obtained from total thymocytes, a population that includes 
immature thymocytes (not yet recombined at the a locus) as well as mature thymocytes 
(which may have divided multiple times since recombination and generation of an al 
TREC). It can therefore be assumed that the actual frequency of cells that recombine to 
generate an al T R E C is higher than the concentration measured from these samples. 
To assess the normal distribution of al T R E C in the lymphoid tissues, two 
normal juvenile macaques were sacrificed (Fig.8). As expected, the al T R E C 
concentration in the thymus of these animals was higher than that in the P B M C , a tenfold 
increase in one animal and a twentyfold increase in the other. 
al T R E C concentrations in the lymph nodes of each animal varied from values 
similar to those obtained in the P B M C to values fourfold higher. This may reflect 
ongoing local processes of stimulation and proliferation of al T R E C bearing cells. 
Alternately, as D N A is extracted from the total cells residing in the lymph node, variation 
in al T R E C concentrations may be due to local differences in the T cell to non-T cell 
ratio in various lymph nodes. 
Intestinal intraepithelial and lamina propria lymphocytes were isolated from the 
ileum, jejunum, and colon of these two animals to determine whether there was a 
significant population of al T R E C bearing cells in these sites. As the gut has been 
implicated as an extrathymic source of T cells, we wanted to be able to compare the 
intestinal lymphocytes of thymectomized macaques to normal values. In the normal 
macaques, the IEL and LPL in the gut contained fewer than 0.5% al TREC bearing cells. 
These low levels indicate both the absence of significant a(3 T C R rearrangement in the 
gut and the absence of large-scale trafficking of al TREC bearing cells from the thymus 
to the gut. It must be remembered that no conclusion can be made about y$ TCR 
rearrangement using this assay. 
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6.3 Impact of Thymectomy on the Peripheral T Cell Pool The functional significance 
of the postnatal thymus has long been the subject of debate. Here we present evidence 
that despite persistent and measurable thymic output, the thymic contribution to the 
peripheral T cell pool is quantitatively insignificant. 
Figure 33A presents a model of the steady-state peripheral T cell pool, in which 
the thymic source (s) and proliferation (p) contribute to the pool, while death (d) depletes 
the pool. In the steady-state, s+p = d. Figure 33B shows the same model with the source 
cut off by complete surgical thymectomy. In this situation, there must either be a decline 
in the total T cell pool or a new steady-state reached with p balancing d. 
B 
s + p = d p = d 
Figure 33. Model of peripheral T cell homeostasis. A. Normal macaque. B. 
Thymectomized macaque. 
From our analysis, we observed that surgical thymectomy did not significantly 
decrease peripheral CD3+, CD4+, or CD8+ T cells (Fig. 9, 10, Table 2). Thymectomy also 
had no effect on the naive populations as measured by the CD45RA isoform (Fig. 11, 12, 
Table 3). The persistence of a steady-state T cell pool could be explained by 1) an 
increase in proliferation, 2) a decrease in death, or 3) no change in proliferation and death 
required because the source before thymectomy was not significantly contributing to the 
pool. W e can rule out explanation 1 immediately because flow cytometry analysis of the 
T cell pool using Ki67 as a marker for cell proliferation revealed no increase in 
proliferation in response to thymectomy (Fig. 13). Although we were not able to measure 
the death rate in this study to directly rule out explanation 2, we will see from the al 
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T R E C analysis that indeed the source before thymectomy is so small as to be 
insignificant, therefore not requiring peripheral compensation to maintain the steady-
state. 
While we observed no change in these parameters during the ten months post 
surgery, it might be expected that a longer period of time would reveal a slow but 
measurable decline of T cells, particularly naive T cells. While the number of cells 
produced by the thymus each day is be quite small, the cumulative effects of thymectomy 
over the lifespan of the rhesus might become more apparent. In this study, the phase of 
thymectomy alone was meant to set the stage for a comparison of athymic and euthymic 
animals in infection, and after the ten months studied the majority of animals were 
infected with SIV. The number of uninfected animals remaining is too small to draw any 
conclusions as to long-term effects of thymectomy, but may in the coming years provide 
an indication of what is to be expected from a larger study of thymectomy without 
infection. 
This phase of the study was also limited by technical aspects of the flow 
cytometry. Flow cytometry provides a fairly accurate profile of the cells studied, but may 
lack the quantitative ability to distinguish small changes in the subsets studied. It is 
possible that processes occurring post thymectomy result in small changes in the 
peripheral T cell pool, too small to be detected using flow cytometry. 
Moreover, the use of additional markers for naive cells and for T cell proliferation 
might reveal changes in the peripheral pool not detected by this study. Future studies 
might include double staining with CD45RA and CD62L (not used in this study due to 
limitations created by freezing cells) for a more specific assessment of naive cells. While 
antibodies to the CD45RO isoform that cross react with rhesus cells are not currently 
available, the creation of these antibodies will allow a direct study of memory cells. In 
addition to the use of Ki67 as a marker for cell proliferation, the early activation marker 
CD69 would also provide evidence of peripheral processes that would affect T R E C 
concentrations. Finally, the use of T U N E L or annexin V staining would yield 
information on cell death in this cohort. 
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6.4 Impact of Thymectomy on al T R E C Bearing Cells A model of the impact of 
thymectomy on peripheral al TREC bearing cells is diagrammed in Figure 34, A and B. 
In the normal state (Fig. 34A), the source of T R E C (sTREC) increases the pool of TREC 
bearing cells, while proliferation (pTREC) and death (dTREC) of those cells decrease the 
T R E C concentration. Cell division decreases the concentration of T R E C in the T cell 
pool, while the death of a TREC-bearing cell results in the loss of the episome itself, 
either one or two copies. Note that s-^^, pTREC, and dTREC are not the same as s, p, and d 
for the total T cell pool, unless one makes the assumption that T R E C bearing cells are 
evenly distributed among processes involving the total T cell pool. 
B 
S T R E C = P T R E C + d j R E C O U t p U t = P T R E C + d T R E C 
Figure 34. Model of al T R E C homeostasis. A. Normal macaque. 
B. Thymectomized macaque. 
After thymectomy (Fig. 34B), there can be no maintenance of the presurgical 
state, as the thymus is the only source for al T R E C bearing cells. While it is possible 
that the proliferation or death rate of that population could decrease to maintain the 
population of recent thymic emigrants, various lines of evidence indicate that this is 
unlikely. First, naive cells are long-lived and divide slowly(195). Second, many studies 
argue against feedback or cross-talk between the thymus and the periphery(24-26). Most 
importantly, data presented here on the increased decay of al T R E C in the 
thymectomized macaques provides evidence that interruption of the source is not 
compensated by peripheral processes. 
The decay of al T R E C bearing cells after thymectomy is reflective of the input 
rate from the source (Fig. 14, 15, Table 4). Our calculation, based on the slope of al 
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T R E C decay in the P B M C of the thymectomized macaque (Fig. 16), is based on some 
numerical assumptions. The first is that the average juvenile macaque has 10" total T 
cells. This is tenfold less than humans, based on size. The second is the percentage of 
total T cells in the juvenile macaque that are al T R E C positive. Our data shows that the 
baseline median T R E C levels in the seventeen animals enrolled at the study was 2.2% of 
P B M C . As any cell can contain one or two al TREC, depending on recombination at 
each chromosome, this translates to a total of l.l-2.2xl09 total al T R E C bearing cells. 
W e make the assumption that al T R E C bearing cells are evenly distributed among the T 
cell compartments; although some lymphoid tissues have higher concentrations than 
others, our tissue al T R E C data supports the assumption that al T R E C bearing cells 
circulate between the blood and tissues, rather than being sequestered (discussed below). 
With these assumptions, we can multiply the decay rate of al TREC bearing cells 
in the P B M C (0.5% of their number per day) by the total al T R E C bearing cells (1.1-
2.2xl09) to obtain an absolute thymic production rate, 5.5-1 lxlO6 cells per day. As only 
1 1 % of single positive thymocytes are al T R E C positive, we expect the total thymic 
export rate to be 11-fold higher, 6.1xl07 to 1.2xl08 cells per day. This value is within the 
range obtained for mice (l-2xl06 cells/day)(l, 3) and sheep (8.5xl07-4xl08 cells/day)(6). 
As a juvenile macaque is intermediate in size between these two species, it makes sense 
that the thymic output, which is believed to be based on thymic mass, is intermediate as 
well(l, 2, 4-6). One might expect that a 7kg monkey, approximately 250 times larger 
than a mouse, would have a 250 fold greater thymic output, of 2.5xl08 cells per day. Our 
calculated export rate of 1.2xl08 cells per day approaches that value. 
While our calculation gives us an estimate of thymic output, it does not take into 
account the age-related decline in al T R E C concentrations seen in euthymic controls. 
While thymectomized animals have a decay rate of 0.5% of al T R E C per day, sham 
controls had a decay rate of 0.1% per day. Adjusting for the age-related decline yields a 
thymic output of 4.4-8.8xl06 al T R E C bearing cells per day, or 4.8-9.7xl07 total cells 
per day. 
Our calculations of thymic output provide a minimum estimate. Residual thymic 
tissue, while not detected on necropsy, would slow the decay of al T R E C bearing cells 
after surgery and decrease our measurement of the actual production rate. 
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W e have thus demonstrated a persistent and measurable thymic output in the 
juvenile macaque, approximately 6.1xl07 to 1.2xl08 cells per day. This number 
represents 0.1 % of the rhesus T cell pool of 10" cells, a small fraction of the total. As 
the loss of this input was not measurable by flow cytometry within the 300 days studied, 
we believe that this output is so small as to require no compensation. While normal levels 
of peripheral proliferation may have been able to maintain the pool over the course of this 
study, it is unknown whether these levels can maintain the pool quantitatively in the long 
run. Over a longer period of time, maintenance of the T cell pool by proliferation alone 
would be expected to result in a qualitative restriction of the T C R repertoire. This is 
consistent with the TCR V(3 restriction observed in the single animal studied 13 months 
post thymectomy. 
6.5 al TREC in the Lymphoid Tissues After Thymectomy Having ascertained that 
the thymus is the sole source of al TREC bearing cells in the normal juvenile macaque, 
we addressed the issue of whether an extrathymic source might develop in response to 
thymectomy. Eight months post surgery, four thymectomized and two sham macaques 
underwent tissue biopsy of lymph node, liver, and intestine, the latter sites chosen as they 
have been reported to be extrathymic sources of T cells (64, 65, 74). The appendix has 
been implicated as a significant site of interest in the intestine. As rhesus macaques do 
not have an appendix, the terminal ileum and cecum were biopsied instead. 
While the two sham controls had a similar profile to the normal juvenile 
macaques, the al T R E C concentrations in the tissues of the thymectomized macaques 
were roughly twofold lower in all tissues studied (Fig. 28, Table 13). This is consistent 
with the decline in al TREC in the P B M C during this period. That removal of the source 
impacts upon the lymphoid tissues as well as the peripheral blood lends support to the 
assumption that there is circulation of al T R E C bearing cells between the blood and 
lymphoid tissues. 
Extrathymic recombination to produce aP T cells would result in a localized 
increase in al T R E C concentration at the site of recombination. No such increase was 
seen in the tissues of the thymectomized macaques, evidence that none of the tissues 
109 
studied were behaving as an alternate site of compensatory aP T cell production. Again, 
y5 T cell recombination events are outside of the scope of this study. 
Moreover, the absence of overall changes in the peripheral T cell pool provide no 
homeostatic pressure for the development of an extrathymic source. Indeed, as thymic 
output is calculated to be so small as to be insignificant, its absence would not be 
expected to be a driving force for compensatory changes in potential extrathymic sites for 
T cell production. 
6.6 TCR Repertoire Restriction After Thymectomy While the quantitative changes 
following thymectomy provide information about thymic output and peripheral T cell 
processes, they do not address the quality of the immune panel following surgery. 
Previous reports that adult thymectomy is not associated with immunological deficit (30-
32, 53) suggest that the qualitative aspects of the T cell pool are unchanged by 
thymectomy. To address this issue in our study, we used T C R V P C D R 3 length 
polymorphism as an indicator of the diversity of the TCR repertoire. 
One representative animal was chosen from each group of the study; 
thymectomized infected, thymectomized uninfected, sham infected, and sham uninfected. 
The twenty-four V P families were studied at baseline, eight months after surgery, and 
three months after infection (thirteen months post surgery). 
Eight months after surgery, the vp profiles in the two thymectomized and two 
sham animals were virtually unchanged (Fig. 32). There were minor shifts in the relative 
frequencies of species within each family in all animals, most likely reflective of normal 
ongoing antigen-recognition processes. However, in all four animals the VP profiles 
were diverse, reflecting a broad immune panel. This is consistent with our observation 
that there was no significant loss of T cells after surgery, and no increase in peripheral 
proliferation that might lead to clonal expansion of individual V P species. 
While two of these four animals were assigned to the infection group, the 
remaining uninfected controls allowed the study of the impact of thymectomy over a 
longer period of time. Thirteen months post thymectomy, uninfected animal AH02 
showed evidence of restriction in the immune panel, while the euthymic control BI25 
continued to have a broad polyclonal TCR panel. This may reflect a slow loss of T cells 
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without thymic replacement, too small to be detected by flow cytometry but evidenced by 
T C R repertoire restriction. Alternately, the number of T cells may be maintained by a 
level of peripheral proliferation that is not marked as elevated by FACS but that results in 
an oligo- or monoclonal expansion of peripheral T cells. 
In an effort to substantiate the observation that thymectomy resulted in restriction 
of the TCR panel beyond the pictorial changes displayed in Figure 32, we used Genescan 
software to define the number of species in each VP family at each time point (Table 14). 
At baseline, the four animals had varying numbers of species within each family, but a 
similar total number of species, ranging from 298 to 405. Eight months post 
thymectomy, there were no consistent changes in number in thymectomized or sham 
animals. However, by thirteen months post thymectomy, the uninfected animal AH02 
had a clear decrease in the sum of species to 4 0 % of the sum at baseline. In the same 
time period, the uninfected sham control BI25 had a slight decrease to 9 6 % of baseline, 
ruling out age-related restriction as an explanation for this phenomenon. It must be 
stressed that this is only one animal, and further studies must be done before a 
generalized conclusion is made. 
It is believed that a diverse T C R repertoire relies on thymopoiesis, while 
expansion of peripheral T cells is limited to the existing population and results in a 
suboptimal immune panel (reviewed in(196)). Thus it is not surprising that there is 
evidence of restriction in the immune panel following thymectomy. The extent of this 
restriction in a larger population and the impact on antigen recognition and immune 
response will require further study on a larger cohort. As there is clinical evidence that 
adult thymectomy does not result in immune deficit, it might be hypothesized that 
restriction of the immune panel after thymectomy is a slow process, and that observable 
deficits might not develop for many years. 
6.7 Thymectomy in the Context of SIV Infection While the hallmark of HIV-1 and SIV 
infection is the progressive loss of T cells, it is not clear whether this loss is due to 
pathogenic effects of the virus on the thymus, direct and indirect cell killing in the 
periphery, or, most likely, some combination of the two. Infection is known to increase 
proliferation by immune activation(96, 197) and to increase cell death(96). It is also 
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believed that there may be an increase in thymic activity after infection(96, 129). A 'tap 
and drain' model has been proposed for HIV-1 infection in which thymic output and 
peripheral proliferation are increasingly outpaced by T cell death. Eventually, the 
balance of input and loss is tipped towards the progressive loss of T cells, resulting in 
immunodeficiency and death. 
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Figure 35. Model of peripheral T cell decay in SIV infection. A. Normal 
macaque. B. Thymectomized macaque. 
W e have demonstrated that thymectomy has a limited quantitative impact on the 
steady-state peripheral T cell pool in the juvenile rhesus macaque. W e next wanted to 
perturb that steady-state to assess the role of the thymus in a situation of T cell decay. 
W e inoculated six thymectomized and six sham macaques with SIVMAC251. In our model 
of peripheral T cell homeostasis (Fig. 35), the 'tap' in the euthymic macaques would 
include both thymic output and peripheral proliferation, and proliferation alone in the 
thymectomized animals (Fig. 35A, 35B). 
It was hypothesized that the absence of thymic output, however minimal, would 
take on greater significance in the context of lymphopenia, and that thymectomy would 
result in a faster rate of C D 4 decline. However, this was not observed (Fig. 19, Table 8). 
The slope of C D 4 decay in the thymectomized animals was not significantly steeper than 
that of the sham animals. Paradoxically, only the animals in the thymectomy group had a 
significantly steeper decline of C D 4 cells compared to their own preinfection values. 
This may suggest a more rapid onset of C D 4 decline in the thymectomized animals, 
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possibly due to the lack of thymic rebound in early infection, but does not ultimately 
translate to lower C D 4 counts or faster progression to death. 
There was also no discernible difference in naive T cell decay between the 
thymectomized and sham animals (Fig. 23, Table 10). While it is believed that HIV-1 
and SIV preferentially infect activated T cells, leading to a decline in the memory 
population, this is a long-term effect of chronic infection that would not be expected in 
the time period under examination(192, 193). 
These observations are consistent with anecdotal evidence that thymectomy 
before HIV-1 infection did not preclude peripheral CD4+ T cell reconstitution or clinical 
response to HAART(53), and suggest that the absence of the thymus does not increase 
the quantitative effects of viral infection on the peripheral T cell pool. 
An increase in T cell proliferation, beyond that observed in infection of a 
euthymic host, might compensate somewhat for the absence of the thymus. W e observed 
that thymectomized animals had an increase in Ki67+ C D 4 T cells as early as 16 weeks 
post infection (Fig. 24). In contrast, sham animals showed a slight increase in Ki67+ CD4 
T cells, with only a few animals exceeding normal values in the 24 weeks studied. 
Antigen stimulation provides a driving force for CD8 proliferation, and in both 
thymectomized and sham animals, there were two phases of increased Ki67+ CD8 T cells. 
There was an initial burst of C D 8 proliferation at 2 weeks post infection, temporally 
correlated with the peak viral load. The percentage of proliferating CD8+ T cells declined 
slightly but remained above normal in the thymectomy group, with a second phase of 
increase at week 24. In the sham group, the percentage of proliferating CD8+ T cells 
declined to the normal range between weeks 9 and 24, and began to increase slightly 
again at week 24. 
The higher percentage of Ki67+ C D 8 T cells in the thymectomized macaques may 
reflect compensation for the absence of source. Alternately, it may reflect a higher level 
of antigen stimulation. There was no clear-cut correlation between viral load and 
percentage of Ki67+ T cells in individual animals of either group. If Ki67 levels indeed 
reflect compensation for the absence of thymic output, it would suggest that in the 
context of SIV infection, thymic output plays a role in the effort to keep a steady-state T 
cell pool. However, a comparison between thymectomy and sham animals indicates that 
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there is adequate compensation for the loss of the thymus. Future studies using more 
markers for T cell activation and proliferation may clarify these issues. 
Finally, thymectomy did not increase progression to death in this cohort. 
In the first six months following infection, four thymectomized and two sham animals 
progressed to simian AIDS and had to be euthanized. This timing is consistent with rapid 
progression, a phenomenon that occurs in SIV-infected macaques. For these animals, 
both thymectomized and sham, viral load was the strongest predictor of death. A third 
sham animal, AI73, had to be euthanized nine months post infection. Although this was 
after the endpoint of this study, it should be noted that this animal had the highest viral 
load among surviving animals at the last time point of the study. This observation is 
consistent with reports that thymectomy in patients with myasthenia gravis does not 
result in general immune deficit(30-32), or greater pathogenesis of HIV-1 infection(ll, 
53). The caveat to this observation is the small number of animals in each cohort. It is 
impossible with this number of animals to determine whether the progression to death 
seen in our study was a factor of thymectomy or inter-animal variation in immune 
response to viral pathogenesis. However, the overall similarities between the 
thymectomized and sham animals in other parameters support our conclusion that 
progression to death was not related to thymectomy in these animals. 
6.8 al TREC in the Context of SIV Infection Pathogenic effects of the virus on the 
thymus and in the periphery are reflected in the decay of al TREC in the infected host, 
and the study of al T R E C as a marker for recent thymic emigrants affords the 
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Figure 36. Model of al T R E C decay in SIV infection. A. Normal macaque. 
B. Thymectomized macaque. 
HIV-1 and SIV infection could decrease the concentration of al TREC bearing 
cells in the periphery by blocking thymic production of new al T R E C bearing cells 
(sTREC), by killing al T R E C bearing cells in the periphery (dTREC), or by stimulating the 
division rate of al T R E C bearing cells (pTREC) (Fig 36, A and B). It has been suggested 
that the decrease in al T R E C is entirely based on pathogenic effects on the thymus(16). 
As support for this theory, Douek et al. assert that peripheral proliferation of naive cells 
occurs slowly, if at all(195), and that it is unlikely that recent thymic emigrants are 
susceptible to HIV infection(192, 193). The same group suggests that H A A R T increases 
al T R E C by increasing thymic output. However, it is equally plausible that H A A R T 
decreases proliferation and death rates, alternate explanations for the increase in al 
T R E C following treatment 17). 
A more sophisticated study of the impact of viral pathogenesis on al T R E C 
demonstrate that peripheral processes, rather than thymic impairment, account for the 
decline in al T R E C after infection. By combining al T R E C measurements in naive T 
cells with mathematical modeling, Hazenberg et al. were able to predict the effect of 
changing individual parameters on al TREC. Blocking thymic production barely 
influenced the average T R E C content or naive cell numbers. Increasing death led to a 
decrease in the number of naive T cells along with an increase in the TREC concentration 
of those cells. Finally, increasing proliferation increased naive cells and decreased 
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TREC. A model of HIV-1 infection involving increased proliferation and death predicted 
a loss in al T R E C and a slow decrease in naive T cell numbers(198). 
Although we assayed al T R E C in C D 4 and C D 8 cells, rather than in naive 
populations, our data support Hazenberg's predictions. In C D 4 cells, infection 
significantly increased the decline of al T R E C in both the thymectomized and sham 
macaques (Fig. 26). Infection also increased the decay rate of al T R E C in the CD8 cells, 
although the decline after infection in the thymectomized animals was not significantly 
faster than that before infection (Fig. 27). 
A comparison of the postinfection al T R E C decay between thymectomy and 
sham indicated that the thymectomized animals had a faster decay rate (Table 12). This 
difference is an immediate indication that the absence of the thymus results in a greater 
loss of recent thymic emigrants in SIV infection. However, we hypothesized that this 
was not due to greater viral pathogenesis in the thymectomized macaques, but rather to 
the preinfection disparity in al T R E C decay caused by thymectomy. To clarify this 
issue, we adjusted the postinfection al T R E C decay slopes for the preinfection values. 
The adjusted decay rates revealed no significant difference between the two groups, 
confirming our suspicion that the impact of infection on al T R E C decay is unrelated to 
the thymus. This indicates that it is peripheral processes disturbed by viral pathogenesis, 
and not blockage of the source, that forms the greater factor al T R E C decay in SIV 
infection. This supports Hazenberg et al.'s modeling of various parameters on al TREC 
decay in infection. 
These data contradict previous assertions that impaired production forms the basis 
for CD4+ T cell decline in HIV-1 infection(16). This hypothesis is based on observations 
of al T R E C decay in infected individuals as well as reports that HIV-1 infects 
thymocytes and disrupts thymic architecture(98, 115, 129, 199). W e agree that the 
thymus is affected by SIV and present evidence that its architecture and function is 
indeed damaged by infection (Fig. 31, Table 13). However, the comparison of euthymic 
and thymectomized animals presented here indicates that disruption of thymic function is 
not as great a factor in predicting al TREC decay and overall CD4+ T cell decline as are 
peripheral processes. 
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Our data support multiple reports that peripheral processes are the predictor of 
CD4+ T cell decline in HIV-1 infection(84-88, 92-97). These studies argue that increased 
proliferation and accelerated destruction result in eventual immune collapse. That our 
thymectomized animals have comparable peripheral T cell dynamics and disease 
progression to euthymic animals indicates that peripheral processes play a major role in 
viral pathogenesis. While it would be impossible to draw a firm conclusion as to the 
relative contributions of impaired production and accelerated destruction in T cell 
decline, it is most likely a balance of the two that eventually leads to opportunistic 
infection and death. 
Due to the rapid loss of most of our infected animals, this study was not able to 
address T cell reconstitution following antiretroviral therapy. W e expect thymic output 
to be crucial in T cell regeneration following therapy. Our hypothesis is that 
thymectomized animals would not be able to fully correct the loss of C D 4 T cells, and 
that T cells regenerated by peripheral expansion would be memory cells. W e also 
suspect that thymectomized animals would not be able to regain a diverse TCR panel. 
Future studies will be able to focus on treatment and the role of the thymus in 
reconstitution in the rhesus macaque. A study of al T R E C increases following treatment 
in euthymic animals may yield quantitative information on the ability of the thymus to 
reconstitute the peripheral T cell pool. 
6.9 al TREC in the Lymphoid Tissues After Infection To examine the impact of SIV 
infection on the concentration of al T R E C bearing cells in the lymph nodes, biopsies 
were taken from all animals at two and nine weeks post inoculation. To strengthen the 
observations made in these samples, we added the lymph node data from those animals 
that had tissue biopsies eight months post thymectomy, before infection, as well as data 
from tissue collected from infected animals at necropsy (Fig. 29). 
As thymectomy resulted in a decreased concentration of al TREC in the 
lymphoid tissues, the thymectomized animals had lower concentrations than the sham 
animals at the start of infection. By nine weeks post infection, both thymectomized and 
sham animals had a drop of approximately one log, from l.lxl04/106 lymphocytes to 
2.7xl03/106 lymphocytes in the thymectomized animals and 2.4xl04/106 to 1.4xl04/106 
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lymphocytes in the sham animals. That both groups had a similar drop due to infection 
indicates that the lower al T R E C concentrations in the thymectomized animals is due to 
the preexisting deficit in al T R E C bearing cells. However, a one log drop in the 
thymectomized group represents a greater relative decline than that in the sham group, 
suggesting a greater pathogenic effect on the thymectomized animals. 
At necropsy, thymectomized animals had lower concentrations than sham controls 
in every lymphoid tissue studied (Fig. 30, Table 13). However, both groups had 
significantly lower concentrations than normal. This suggests that SIV infection has a 
pathogenic effect on al T R E C bearing lymphocytes in the tissues as well as the blood, 
and that al T R E C bearing cells may circulate freely between the blood and tissues such 
that the effects of viral pathogenesis are evenly distributed. 
The only tissue that had a normal al T R E C in the infected sham macaques was 
the spleen. In the thymectomized animal the al T R E C concentration in the spleen was 
nearly two logs lower. It is possible that an increased al T R E C concentration is 
associated with inflammatory processes in this tissue. Two thymectomized animals with 
granulomatous inflammation of the spleen secondary to Mycobacterium avium had higher 
al T R E C concentrations in the spleen. Although one sham animal did not show 
histologic evidence of inflammation of the spleen, the pathology report on the other has 
not yet been obtained. A final caveat is that al T R E C were measured as a fraction of 
total splenocytes rather than T cells in the spleen, and thus may reflect disparate overall T 
cell counts in that organ between the two groups. 
al T R E C bearing intestinal lymphocytes were virtually undetectable in both 
thymectomized and sham groups. This is most likely reflective of the overall loss of 
lymphocytes in the gut, and the possibility that those remaining are not canonical aP T 
cells. 
Finally, seven animals were examined for the presence of residual thymic tissue at 
necropsy. No thymic remnants were found in the four thymectomized macaques, 
assurance that surgical thymectomy was complete. Involuted thymic tissue was present 
in the three sham animals. The concentration of al T R E C in one thymus sample was 
3.33xl04/106 thymocytes, threefold lower than the average normal concentration of 
9.1xl04/106. Histological examination of the same thymic tissue on necropy revealed 
118 
further evidence of pathogenic effects on the thymus, including atrophy, loss of 
cellularity, and infiltration of fat (Fig. 31). This is consistent with multiple lines of 
evidence that HIV-1 and SIV infect the thymus (reviewed in(50)). 
6.10 TCR Repertoire Restriction After Infection Three months after infection, the one 
thymectomized and one sham animal studied both showed evidence of dramatic 
restriction of the T C R repertoire by C D R 3 length polymorphism analysis (Fig. 32). 
Visual inspection reveals a marked decrease in the species within each family, from 
multiple peaks of varying frequency to a single dominant peak or a small number of 
peaks. This shift from polyclonal to mono- or oligoclonal response is reflective of the 
antigenic simulation and clonal expansion processes taking place in infection. 
Analysis of the sum of species in these two macaques indicates that the restriction 
was more profound in the thymectomized animal than in the sham control (Table 14). 
Three months post infection, the sum of species in the sham animal AP19 was 6 0 % of 
that at baseline for the study, while the sum of species in thymectomized animal AI25 
was 2 7 % of that at baseline. This difference is not surprising, as thymectomy alone over 
this period resulted in a 40%' decrease in the sum of species. 
It was initially reported that SIVMAC infection does not result in restriction of the 
T C R VP repertoire(179). However, that study was based on estimates obtained from 
autoradiograms of PCR product, and focused in the relative frequency of each VP family. 
This technique cannot be used to examine the changes in species within each family. In 
fact, a shift from multiple species of similar length to a single species might not affect the 
cpm detected from a band on a gel. Using PCR based spectratyping, differences in length 
as small as a single base pair can be detected within each family. Our results are 
consistent with Chen et al.'s initial study in that the overall contribution of each VP 
family to the total is not dramatically changed, however we had the opportunity to 
monitor minute changes within each family. It must be noted that neither technique has 
the ability to detect base pair substitutions in a species of a given length. 
More recent studies by Chen et al. using the Genescan based length 
polymorphism assay revealed that there was indeed clonal dominance among CD4+ T 
cells in macaques infected with SIV(200). These findings are consistent with our own, 
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although we studied total P B M C rather than sorted C D 4 cells. This study suggests that 
the dominant clones are SIV-specific cells. Other studies, using this method of 
spectratyping as well as VP-chain specific monoclonal antibodies, have also 
demonstrated skewing in the CD8+ T cell population(152, 201) and sorted CD45RA+ and 
CD45RO+ populations(202) in HIV-1 and SIV infected hosts. 
A future study of particular interest in this area will involve the treatment of 
thymectomized, infected animals with H A A R T , to ascertain whether any restoration of 
the T C R repertoire is possible. There is evidence for a polyclonal background underlying 
dominant C D R 3 populations in SIV infected macaques(200) as well as HIV-1 infected 
humans (L. Zhang, personal communication). The extent of this background in the 
thymectomized host has yet to be determined. 
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7. Conclusion 
Here we present evidence that the quantitative contribution of the thymus to the 
peripheral T cell pool is minimal. Surgical thymectomy in the juvenile macaque did not 
cause a detectable loss of peripheral T cells or a shift in naive and memory populations. 
No compensatory extrathymic source was detected, nor was proliferation induced as a 
compensatory mechanism. This is consistent with previous studies that described 
minimal immunological deficits following thymectomy in the clinical setting. 
It has long been believed that after the initial seeding of the T cell pool, the 
thymus ceases to play a role in T cell homeostasis. Initial studies on the al TREC as a 
marker for recent thymic emigrants in humans proposed the novel conclusion that thymic 
function is present well into old age. This study of al T R E C decay in the 
thymectomized macaque provides evidence that thymic output, while measurable, is 
numerically minimal in the context of the total T cell pool. 
SIV infection has a profound impact on T cell homeostasis. SIV has destructive 
effects on T cells in the thymus and the periphery, and results in high levels of antigen-
stimulated proliferation. Our results demonstrate that the absence of the thymus does not 
create a situation of higher viral load, greater T cell decay or progression to death. The 
increased proliferation in the thymectomized animals may be due to antigen stimulation 
or to compensate for the absence of thymic output. In either case, it is sufficient to 
maintain the declining T cell pool at the same levels seen in the euthymic controls. 
Infection can decrease the concentration of al T R E C bearing cells in the 
periphery by a combination of blocking the source, increasing proliferation, and 
increasing death. Our data demonstrates that the al T R E C decay after infection is mainly 
predicted by proliferative dilution. 
Taken together, these data show that peripheral processes, rather than thymic 
output, form the basis for peripheral T cell dynamics, both in the normal macaque and in 
the context of SIV infection. 
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